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REGULATION OF HORMONE-SENSITIVE LIPASE (HSL) BY HIGH-FAT DIET AND 
ARSENIC IN  VISCERAL AND SUBCUTANEOUS ADIPOSE TISSUE IN MICE
Andrea Díaz-Villaseñor1, Diana Calderón-DuPont1,2, Jessica Karen Tello Casillas3,  
Alejandra Contreras4,5, Luz María Chiu-Velázquez1, and Sofía Morán-Ramos4
1Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, 
UNAM, México City, México; 2Postgraduate student Biomedical Sciences, UNAM, México City, México; 3Posgrado 
en Nutrición Clínica, Universidad Anahuac; 4Unidad de Genómica de Poblaciones aplicada a la Salud, INMEGEN, 
México City, México; and 5Fox Chase Cancer Center, Philadelphia, USA
Lipolysis, the hydrolysis of triglycerides into three fatty acids 
and one molecule of glycerol, is one of the main functions of 
white adipose tissue and is impaired in obesity. The proper 
activation of hormone-sensitive lipase (HSL) is crucial for 
stimulated Lipolysis during fasting. Environmental factors 
like high-fat diet (HFD) and metabolism-disrupting chemi-
cals, like arsenic, play an important role in adipose tissue dys-
functionality. However, little is known about how arsenic con-
tributes to Lipolysis impairment in combination with HFD. 
Thus, C57BL/6 male mice fed control low-fat diet (LFD) or 
HFD were exposed to arsenic (100 µg/L) in drinking water 
for 8 weeks. Fasting glycerol, a lipolysis marker, decreased 
in mice fed HFD and this was more evident in combination 
with arsenic exposure. To identify the adipose tissue pads re-
sponsible of these changes, HSL mRNA, total HSL, and HSL 
phosphorylated at Ser660 (activation site) and Ser565 (inacti-
vation site) were measured in retroperitoneal and epididymal 
visceral adipose tissue (rVAT and eVAT, respectively) and in 
subcutaneous adipose tissue (SAT). Of the three adipose tis-
sue pads, SAT had the lowest HSL amount. In rVAT and SAT, 
the phosphorylation in the activation site was decreased 50% 
only in mice fed HFD and exposed to arsenic simultaneously. 
However, SAT had half of the amount of pHSL660 in mice fed 
the control LFD. In eVAT, the phosphorylation in the activa-
tion site was decreased 60% by HFD and was more evident in 
combination with arsenic, lowering an extra 15%. When con-
sidering both HSL phosphorylation sites together, the ratio of 
the levels of phosphorylation at the activation and inhibition 
sites indicates a reduction of HSL activity by 50% only in rVAT 
of mice fed HFD and exposed to arsenic simultaneously. In 
summary, arsenic impairs stimulated lipolysis mainly in rVAT 
when mice are fed HFD.
Adipobiology 10, 2019
575th International Symposium on Adipobiology and Adipopharmacology (ISAA)
ANGIOTENSIN 1-7 AS AN INDUCER OF THE BROWNING CAPACITY OF WHITE 
ADIPOSE TISSUE
Ariana Vargas-Castillo, Nimbe Torres, and Armando R. Tovar
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F.
Angiotensin-(1-7)[Ang-(1-7)], a component of the renin an-
giotensin system is a vasodilator that exerts its effects particu-
larly via Mas receptor. The antihypertensive drugs that inhibit 
the Angiotensin Converting Enzyme, such as captopril, in-
crease Ang-(1-7) serum concentrations and have been associ-
ated with a reduction or prevention of weight gain in humans 
and animal models. The discovery of Mas receptor in white 
adipose tissue (WAT) suggests an additional role of this pep-
tide. It is unknown if Captopril or Ang-(1-7) can activate the 
differentiation of beige adipocytes, a process called browning/
beiging and partly explain the prevention of weight gain. Beige 
adipocytes are thermogenic cells that express uncoupling pro-
tein 1 (UCP1), have a higher mitochondria abundance and 
are associated to an increase in energy expenditure. In vitro 
experiments in adipocytes showed that a treatment with Cap-
topril or Ang-(1-7) induced the expression of thermogenic 
genes and mitochondrial respiration. On the other hand, in 
vivo experiments showed that an infusion of Ang-(1-7) in-
creases energy expenditure and induces the mRNA expression 
of Ucp1 and some beige markers in the inguinal white adipose 
tissue (iWAT) from Mas+/+ mice, effects that were abolished in 
Mas-/- mice. The lack of Mas receptor increased body weight 
gain and decreased cold resistance whereas rats overexpress-
ing Ang-(1-7) showed the opposite effects. These data indicate 
that Ang-(1-7) is a new factor that induces browning/beiging 
of iWAT through Mas receptor and has the therapeutic poten-
tial to induce thermogenesis.
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ADIPOSE TISSUE REMODELING IN OBESITY
Gutiérrez Aguilar Ruth 
División de Investigación, Facultad de Medicina, Universidad Nacional Autónoma de Mexico, UNAM, and 
Laboratorio de Enfermedades Metabólicas, Obesidad y Diabetes, Hospital Infantil de México “Federico Gómez”, 
Mexico City, Mexico
Obesity is a chronic disease, affecting 32% of adults in Mexico. 
Obesity increases the risk to develop type 2 diabetes, dyslipi-
demias, and hypertension, representing the second cause of 
clinical visits in Mexico. Obesity is defined as an excessive 
increase of adipose tissue. The excess of fatty acids provokes 
the adipocytes to become hypertrophic. This adipocytes ex-
pansion provokes an increment in hypoxia, inflammation and 
an inadequate vascularization on the adipose tissue, leading 
to a reduction of its functionality. In addition, the reduction 
of vascularization (angiogenesis) in adipose tissue contrib-
uted to weight loss, reducing fat mass and food intake. Also, 
glucose homeostasis was ameliorated and triglycerides were 
decreased. Adipose remodeling, defined by angiogenesis, hy-
poxia and inflammation, has recently been suggested to con-
tribute to metabolic modifications, causing susceptibility to 
obesity. The comparison between animals prone to obesity 
and resistant to obesity demonstrated that adipose remod-
eling was higher in prone animals. These findings suggested a 
mechanism that might contribute to develop obesity.
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SEXUAL DIMORPHISM: A FACTOR IN THE INSULIN RESISTANCE MECHANISM  
IN METABOLIC SYNDROME MODEL
Myrian Velasco, Rosa Isela Ortiz Huidobro, Carlos Larqué and Marcia Hiriart
Institute of Cellular Physiology-UNAM, México City, Mexico
Metabolic syndrome (MS) is a cluster of metabolic signs that 
increases the risk to develop type 2 diabetes mellitus and car-
diovascular disease. Metabolic syndrome includes the next 
signs: central obesity, insulin resistance, impaired fasting glu-
cose, hypertension, and dyslipidemia (hypertriglyceridemia 
and low HDL). Although it has been proposed that some of 
these signs are different between female and male, the insulin 
resistance mechanisms in metabolic syndrome are unknown. 
Thus, the objective of this work was to analyze the insulin sign-
aling pathway in adipose tissue comparing female and male in 
a metabolic syndrome model in rats. We used Wistar female 
and male rats (250-280 g), which were fed with standard diet 
and 20% of sucrose in drinking water (treated group) or plain 
water (control group) during 24 weeks. After this time, both 
female and male treated rats developed MS with central obe-
sity, hyperinsulinemia, insulin resistance, high triglycerides in 
plasma. Furthermore, male treated rats developed hyperten-
sion and hyperglycemia. We studied total and phosphorylated 
AKT and P70S6K1 (S6K1) proteins in peripancreatic (PAT) 
and gonadal (GAT) adipose tissue. According to the results, 
phosphorylated AKT1 (S473) protein increased in peripan-
creatic adipose tissue of both female and male treated animals, 
while p-S6K1 diminished in male treated and there were no 
differences in female rats. In gonadal adipose tissue p-AKT1 
and p-S6K1 proteins didn’t change between treated and con-
trol male rats. While in the female p-AKT1 diminished in 
treated in comparison with control rats, without changes in 
the p-S6K protein. Our results showed that MS impaired the 
insulin signaling pathway and these changes are different be-
tween female and male rats. 




THE COGNITIVE ADIPOBIOLOGY: A GOLD MINE TO BE UNFOLDED
George N. Chaldakov1, Luigu Aloe2, Marcia Hiriart3, Marco Fiore4, Stanislav Yanev5, and  
Marin Zhelezov1
1Department of Anatomy and Cell Biology, Medical University, Varna, Bulgaria, 2Fondazione Iret Tecnopolo R. 
Levi-Montalcini, Rome, Italy, 3Department of Cognitive Neuroscience, Instituto de Fisiología Celular, Universidad 
Nacional Autónoma de México, Mexico city, Mexico, 4Institute of Cell Biology and Neurobiology, National 
Research Council (CNR), Rome, Italy, and 5Institute of Neurobiology, Department of Drug Toxicology, Bulgarian 
Academy of Sciences, Sofia, Bulgaria
The present lecture dealing with cognitive adipobiology (cog-
nitive adiposcience), focusing on the pathogenesis of Alzhei-
mer’s disease. Although the human brain is nearly 50 percent 
lipids, the brain is the only organ which does not contain adi-
pose tissue, except that located at the parasellar region. The 
brain is a bona fide organ mediating cognitive processes. These 
require collaboration with other organs, adipose tissue being 
an example of such mutuality. Adipokines are signaling pro-
teins secreted from adipose cells which influence other tissues 
including the brain. These interactions could be disrupted in 
the setting of obesity. Early stage adipose accumulation is cru-
cial for a healing process, a sustained long-lasting phase may 
trigger pathogenic changes including cardiometabolic and 
neurodegenerative (neurometabolic) diseases. The adipose 
tissue and the brain are both reciprocally and homeostati-
cally regulated. A healthy adipose tissue is essential for both a 
healthy metabolism and a healthy brain. Today, adipose tissue 
is increasingly “getting nervous” secreting NGF, BDNF, mete-
orin (Metrn) and other neurotrophic factors, also neuropep-
tides. Metaphorically, adipose tissue is increasing dramatically 
its intelligence quotient (IQ). We have even proposed that this 
fascinating tissue might function as a third brain, as well as 
the gut is commonly considered a second brain. When the 
adipose tissue gets sick, secondary to inflammatory cell in-
filtration, its dysbalanced endocrine activity represents a risk 
factor for cardiometabolic and neurometabolic diseases. The 
inflamed adipose tissue is a malfunctioning endocrine organ 
which may infect the brain with amyloid precursor peptide 
(APP), β-amyloid peptide, presenilin and other neurodegen-
erative substances, leading to Alzheimer disease. In a similar 
vein, high fat diet fed mice demonstrated a significant increase 
in APP expression and a decrease in the number of dendritic 
spines in brain neurons. In a nutshell, the early detection of 
brain-targeting alzheimerogenic adipokines and the identi-
fication of novel adipose-brain mechanisms may represent a 
gold mine to indeed be unfolded.
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INFLAMMATORY MARKERS IN THE SERUM OF PRE-PUBERTAL CHILDREN  
WITH DOWN SYNDROME
Valentina Carito1, Giampiero Ferraguti 2, Luigi Tarani3, Ginevra Micangeli3, Carla Petrella1, 
Mauro Ceccanti4, and Marco Fiore1
1Institute of Cell Biology and Neurobiology, National Research Council (IBCN-CNR), Rome; 2Department of 
Cellular Biotechnologies and Hematology and 3Department of Pediatrics, Child Neurology and  
4Centro Riferimento Alcologico Regione Lazio, Sapienza University of Rome, Rome, Italy
Down’s Syndrome (DS), also known as trisomy 21 for the 
presence of an extra copy of the chromosome 21 that leads to 
a set of cognitive and physical symptoms, is one of the most 
common chromosomal disorder occurring in about 1 in 800 
newborns world-wide. Although DS individuals are mostly 
perceived as characterized by some distinct physical features, 
cognitive disabilities and cardiac defects, they also show im-
portant deregulations of metabolic and immune functions. In 
this study, we evaluated serum levels of nerve growth factor 
(NGF) and brain-derived neurotrophic factor (BDNF) and 
some markers of oxidative stress in patients with DS since 
NGF and BDNF are known to play subtle roles in the regula-
tion of oxidative, cardiometabolic and immune physiological 
related events [1–4]. The pre-pubertal sample population con-
sisted of 5 male children and 4 female children diagnosed by 
both a pediatric geneticist and a molecular analysis. Six pre-
pubertal healthy baby-girls and 6 pre-pubertal healthy baby-
boys were included in the study as controls. Venous blood 
samples were collected and NGF and BDNF levels were meas-
ured by ELISA assay. The mean NGF serum levels of the pre-
pubertal DS patients were no significantly different compared 
to the controls. However, BDNF serum levels were significant 
higher in DS subjects compared to controls. Oxidative stress 
was analyzed as free oxygen radicals defense (FORD) and free 
oxygen radicals test (FORT) in association with a panel of 
cytokines whose expression levels are strongly influenced by 
NGF/BDNF. Data show that in Down children serum Inter-
leukin (IL)-1β, IL-2, IL-6 and IL-12 are significantly reduced. 
Our study suggests a potential role of BDNF/NGF pathway as 
diagnostic marker of immune, metabolic and central nervous 
systems trophic disconnections in pre-pubertal Down chil-
dren.
1. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova 
MG, Antonelli A, et al. Neurotrophin presence in human 
coronary atherosclerosis and metabolic syndrome: A role 
for NGF and BDNF in cardiovascular disease? Prog Brain 
Res 2004; doi:10.1016/S0079- 6123(03)46018-4.
2. Fiore M, Chaldakov GN, Aloe L. Nerve growth factor as 
a signaling molecule for nerve cells and also for the neu-
roendocrine-immune systems. Rev Neurosci 2009;20:133–
45. doi:10.1515/REVNEURO.2009.20.2.133.
3. De Nicoló S, Tarani L, Ceccanti M, Maldini M, Natella F, 
Vania A, et al. Effects of olive polyphenols administration 
on nerve growth factor and brain-derived neurotroph-
ic factor in the mouse brain. Nutrition 2013;29:681–7. 
doi:10.1016/j.nut.2012.11.007.
4. Carito V, Ceccanti M, Tarani L, Ferraguti G, N. Chaldakov 
G, Fiore M. Neurotrophins’ Modulation by Olive Polyphe-






National Autonomous University of Mexico-UNAM, Mexico City, Mexico
Obesity is a condition that can be recognized on sight by 
anybody with no medical training, yet characterizing it pre-
cisely has proven surprisingly difficult. All the proposed ways 
to measure obesity are plagued by methodological problems 
which make statistical connections with other conditions 
shaky. Exploring some of these methodological intricacies 
unveils several problems about the ways we establish what is 
normal, and therefore what count as being overweight. Ethi-
cal considerations about the way in which socially established 
notions of desirability impact what we consider normal, reveal 
the need to find a notion of normalcy that is independent of 
social conventions. Under an intuitively attractive biomedical 
definition of health and disease, obesity’s characterization is 
found to be as elusive as with purely statistical or social criteria 
of normalcy. This result, coupled with moral considerations 
about the limits to possible measures to fight the obesity epi-
demic, requires us to question the advisability of treating obe-
sity at all. Moral considerations of what constitutes the good 
for us, allow us to understand the proper role of medicine, 
beyond the treatment of disease, understood from the bio-
medical point of view. These same considerations support the 
idea that obesity should indeed be treated even if its status as a 
disease is suspect. Finally, I contend that the awareness of the 
moral impact of obesity on people’s lives, should be a crucial 
element in the efforts to effect the behavioral changes needed 
for patients to successfully fight obesity.
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FLUVOXAMINE’S MECHANISTIC ROLE IN HFD INDUCED TISSUE DYSFUNCTIONS 
THROUGH PPAR-Γ, ADENOSINERGIC-R AND ENOS
Gill Tarun1, Kaur Barinderjit1, Duggal Navneet1, Verma Surajpal1, Kaur Kamaljeet3, and  
Singh Manjinder2
1School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab; 2Government 
Polytechnic College, Amritsar, Punjab, (Government of Punjab, India); 3Amandeep Hospital, Amritsar,  
sPunjab, India
Obesity is growing globally in developing and developed 
countries. Intake of high calorie diet leads to vital organ dys-
functions due to alterations in various biochemical and histo-
logical parameters. Our study signifies that intake of high fat 
diet (HFD), results in escalation of morphological parameters, 
lipid parameters and glucose level. Increased HFD intake cul-
minates cardiac dysfunctions, hepatic impairment, renal in-
juries, elevated oxidative stress and alterations in histopathol-
ogy. Treatment with fluvoxamine attenuates the vital organ 
dysfunctions and same was reversed by BADGE, caffeine and 
L­NAME. Hence, it has been proved the mechanistic role of 
fluvoxamine in high fat diet induced vital organ dysfunctions 
in rats through PPAR-γ, adenosinergic receptors and eNOS.
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DIETARY BIOACTIVE COMPOUNDS AND THEIR ABILITY TO INDUCE WHITE 
ADIPOSE TISSUE
Armando R. Tovar, Ariana Vargas, and Nimbe Torres
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, D.F.
White adipose tissue (WAT) can differentiate into beige adi-
pose tissue by the browning process. Some polyphenols, in-
cluding isoflavones, particularly genistein, are suggested to in-
crease the expression of browning markers. There is evidence 
that consumption of genistein can attenuate body weight gain 
and improve glucose tolerance and blood lipid levels. We have 
demonstrated that genistein can stimulate the browning pro-
cess by at least two mechanisms. An indirect mechanism was 
involved in the induction of PGC-1α/FNDC5 in skeletal mus-
cle leading to an increase in the myokine irisin. In preadipo-
cytes, irisin can increase the expression of Ucp1 and Tmem26, 
markers of browning, to increase energy expenditure. Gen-
istein was also able to activate browning by a direct mecha-
nism. Incubation of preadipocytes with genistein increased 
UCP1 expression as well as some biomarkers of browning in a 
concentration-dependent manner, possibly via phosphoryla-
tion of AMPK. The effect of genistein was accompanied by 
an increase in the number of mitochondria as well as in the 
maximum respiration rate of the adipocytes. In conclusion, 
genistein can increase energy expenditure by stimulating the 
browning process directly in preadipocytes and indirectly by 
increasing the circulating levels of irisin.
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MULTIPLE FACES OF ADIPOSE INFLAMMATION:  
MORPHOLOGICAL ANALYSIS OF CLINICAL CASES
Peter Ghenev, Hristo Popov, Pavel Pavlov, and George Stoyanov 
Department of General and Clinical Pathology, Medical University, Varna, Bulgaria
Human adipose tissue is partitioned into two large depots 
(visceral and subcutaneous) and many small depots asso-
ciated with various organs. Recent evidence accumulated 
about the role of adipose tissue in variety of pathological pro-
cesses ranging from cardiometabolic to neurodegenerative 
and oncological diseases. However, data in regard to histol-
ogy of adipose inflammation in cellulitis is surprisingly few. 
The range of adipose inflammation in cellulitis encompasses 
a broad spectrum – from severe life- threatening conditions 
to wide-spread cosmetic defects. Acute cellulitis is a bacterial 
infection involving the dermis and the hipoderma. Although 
the term “cellulitis” refers specifically to a skin infection, the 
chronic variant is also known as “orange peel skin”, closely re-
lated to the loss of skin firmness and fatty accumulation in the 
hipoderma. Cellulitis, both acute and chronic, is a matter of 
consideration predominantly on the basis of etiology, clinical 
course, treatment and mortality. Here we provide histological 
results from human biopsy and postmortem examinations of 
eight clinical cases of infectious and non-infectious cellulitis 
and two cases of inflammation of the epicardial adipose tissue. 
In the area of acute inflammation adipocytes are surrounded 
by various types of inflammatory cells, predominantly poly-
morphonuclears, and undergo necrosis, size change and small 
blood vessel vasculitis. In case of chronic cellulitis, the adipose 
tissue is infiltrated by inflammatory cells such as macrophages 
and lymphocytes and show areas of fibrosis. It is suggested that 
inflammatory processes, especially in the long lasting chronic 
cellulitis, probably contribute to modulation in the synthetic 
and secretory activities of adipose tissue cells or, vice versa.
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BENEFITS OF HUMAN AND BOVINE COLOSTRUM IN HEALTH AND DISEASE
Buttar Harpal
Department of Pathology & Laboratory Medicine, University of Ottawa, Faculty of Medicine, Ottawa,  
Ontario, Canada
E-mail: hsbuttar@bell.net
Human and mammalian newborns receive colostrum from 
their mothers during the first 24- 48 hrs after birth. Since co-
lostrum is secreted in more concentrated form during the first 
8 hrs post-delivery, the readily available naturally produced 
nutrients and antibodies are delivered to the suckling new-
born in a highly-concentrated and low-volume format. Some 
mothers may not be able to breastfeed their babies, and their 
infants may get the necessary bioactive ingredients present in 
bovine colostrum (BC). There is emerging evidence that BC 
may be one of the promising nutraceuticals which can prevent 
or mitigate various diseases in newborns and adults. Immuno-
globulins, lactoferrin, and other important nutrients present 
in colostrum are known to build natural life-long immunity in 
newborns, which helps to reduce mortality in this population. 
It has been reported that BC has more than 100- to 1000- folds 
higher nutritional value as opposed to human colostrum. BC 
is rich in immunoglobulins, lactoferrin, anti-oxidant, anti-
inflammation, anti-microbial, immune boosting, and growth 
promoting factors, which enhance tissue growth and matura-
tion of the digestive tract and immune function in human and 
animal neonates. As opposed to milk, BC has lesser amount 
of lactose, and therefore may be suitable for patients suffer-
ing from lactose intolerance. Limited number of clinical stud-
ies done in humans and animals with BC supplements has 
shown promising results for curing diseases like AIDS, car-
diovascular and gastrointestinal disorders, infectious diseases, 
wound healing, and certain cancers. BC seems to be a treasure 
trove which if tapped could confer many health benefits and 
cost- effective cures in humans. However, well-designed, ran-
domized, double-blind, placebo- controlled studies with BC 
products are needed to widen their therapeutic role. The ob-
jectives of this communication are to create awareness about 
the nutraceutical properties of BC, and to discuss the various 
prophylactic and therapeutic applications of BC and its bioac-
tive ingredients in humans.
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HYPOTHALAMIC INTEGRATION OF ENERGY METABOLISM
Ruud M. Buijs 
Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico
The brain is in charge of controlling our behavior and physi-
ology; nothing inside our body takes place without that the 
brain is informed. Sensory metabolic information to the brain 
is transmitted via the blood stream and via sensory nerve 
endings in our organs, such as the stomach, liver, fat tissue or 
muscles. This information is conveyed to hypothalamic cent-
ers where decisions are made resulting in behavioral action 
or changes in physiology and associated hormonal or meta-
bolic balances. In principle this leads to a perfect homeostasis 
whereby food intake and energy expenditure keep each other 
in balance. Thus the question arises why in so many condi-
tions this balance is not achieved. To answer this question it 
is important to realize that the received feedback can be over-
ruled by other areas of the brain that may ignore the signals 
of the hypothalamus. Important for a balance in metabolism 
is: 1. food intake should not exceed the daily metabolic need, 
and 2. Food should be taken at the right time of the day. For 
both conditions several hypothalamic mechanisms have been 
developed that are in general the same in most mammalian 
species. One system, the arcuate nucleus, is especially involved 
in the sensing of short term and long term metabolic balance, 
taking into account the amount of body fat and the levels of 
circulating glucose. The other system, the suprachiasmatic 
nucleus or circadian system, takes into account, when to eat, 
so that digestion takes place at an optimal time. Interestingly 
there is a close interaction between the circadian system and 
the arcuate nucleus whereby the exchange of information 
leads to an adequate setting of metabolic conditions. This in-
teraction leads to an organized output of the hypothalamus 
adapting behavior and physiology according to the time and 
the metabolic status of the individual. When the individual 
decides to ignore the signals of the arcuate and circadian sys-
tem resulting in aberrant food intake both in quantity and 
time, this will also result in undesired physiological changes. 
Violating frequently these hypothalamic signals will result in 
obesity and metabolic syndrome.
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PROLACTIN PROMOTES ADIPOCYTE FUNCTION, ADIPOSE TISSUE FITNESS  
AND METABOLIC HOMEOSTASIS: IMPLICATIONS FOR OBESITY
Yazmín Macotela, Xarubet Ruiz-Herrera, Natalia García-Orihuela, Antonio J. Ponce,  
Rogelio I. Servín-Uribe, Gonzalo Martínez de la Escalera, and Carmen Clapp
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 
76230 Querétaro, México
The hormone prolactin (PRL) promotes adaptive changes 
under metabolic challenge. Prolactin (PRL) circulating levels 
are reduced in patients and rodents with insulin resistance, 
whereas PRL treatment promotes systemic insulin sensitivity 
and adipose tissue healthy expansion in high fat diet (HFD)-
fed rats. In agreement, PRL receptor (PRLR) null mice sub-
jected to HFD show aggravated insulin resistance and adipos-
ity. The effects of PRL promoting metabolic homeostasis and 
adipose tissue fitness involve direct actions on preadipocytes 
and adipocytes. Reduced PRLR expression in primary preadi-
pocytes by shRNA-lentiviral vectors diminishes the expres-
sion of the key adipogenic transcription factors: peroxisome 
proliferator-activated receptor gamma (PPARg) and CCAAT/
enhancer- binding protein alpha (C/EBPa), in turn, prevent-
ing differentiation into mature adipocytes. Likewise, down-
regulation of PRLR expression in mature adipocytes results in 
decreased expression of genes relevant for adipocyte function 
such as PPARg, Glucose Transporter 4 (GLUT4), adiponectin, 
and leptin. Furthermore, PRL is able to prevent tumor necro-
sis factor α-induced insulin resistance in cultured adipocytes, 
by increasing AKT phosphorylation, particularly in cells from 
the visceral adipose depot. Finally, lower PRL serum levels 
correlate with insulin resistance and visceral fat adipocyte 
hypertrophy in humans. Altogether, our findings demon-
strate that PRL promotes adipose tissue fitness via stimulat-
ing adipocyte differentiation, function, and insulin sensitivity. 
Because, high PRL circulating levels, within the physiological 
range, are required to maintain metabolic homeostasis, PRL 
enhancing drugs have therapeutic potential in obesity-related 
metabolic diseases. 
This work was supported by National Council of Science 
and Technology of Mexico (CONACYT) grants: Fondo Secto-
rial de Investigación para la Educación 284771, and FOSISS 
261168 to YM.
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VISUALIZING THE METABOLIC RESPONSES OF STIMULATED NEURONS 
USING GENETICALLY-ENCODED BIOSENSORS AND FLUORESCENCE LIFETIME 
MICROSCOPY
Carlos Manlio Díaz-García, Rebecca Mongeon, Carolina Lahmann, Dorothy Koveal,  
Hannah Zucker, and Gary Yellen
Department of Neurobiology, Harvard Medical School, Boston, MA, USA
Energy utilization by the brain is both high and highly dy-
namic. During brain excitation, the local increases in both 
blood flow and glucose consumption substantially exceed the 
increase in oxygen consumption in the activated area. This 
mismatch suggests that glycolysis transiently surpasses the 
capacity of fuel oxidation by the mitochondria, resulting in 
lactate production. However, the cellular site of this aerobic 
glycolysis is still controversial. A popular hypothesis proposes 
that glycolysis is elevated in astrocytes, which then transfer 
lactate to neurons for its oxidation. To determine if neurons 
utilize lactate or perform aerobic glycolysis during stimula-
tion, we expressed genetically-encoded fluorescence lifetime 
biosensors in dentate granule neurons (DGNs) from acute 
hippocampal slices. These sensors allow the quantitative as-
sessment of cellular metabolism with high spatial and tempo-
ral resolution. We measured the cytosolic NADH/NAD+ ratio 
(NADHCYT) in neurons using the sensor Peredox, along with 
the Ca2+ sensor RCaMP1h as readout of neuronal activity. We 
find that the transient increase in NADHCYT correlates with 
the level of activity in neurons, for both synaptic and antidro-
mic stimulation. Blockade of monocarboxylate transporters 
(MCTs) does not abolish this increase, as predicted from the 
idea of lactate transfer from astrocytes, but rather enhances 
the increase of NADHCYT in stimulated DGNs. This result in-
dicates that the neuronal metabolic response does not depend 
on lactate uptake; instead, neurons are likely to perform glyco-
lysis and to be exporters of lactate during activation. Using the 
glucose sensor iGlucoSnFR-TS (formerly called SweetieTS), 
we observed small transient drops in [glucose]i that had a very 
similar time course to the NADHCYT transients, and their be-
havior was consistent with increased neuronal consumption 
of glucose. Changes in [glucose]i are also influenced by NA-
DH-to-NAD+ recycling in neurons: MCT inhibition decreases 
the stimulation-induced dips reported by the glucose sensor. 
Taken together, our results suggest that neurons rely on glu-
cose rather than astrocytic lactate during stimulation.
This work was supported by NIH grants R01 NS055031 
and DP1 EB016985 (to G.Y.); NIH fellowships F32 NS080455 
(to R.M.), F32 NS093784 (to C.L.), and F32 NS100331 (to 
C.M.D.-G.); a David Mahoney Fellowship (to R.M.); and a Fix 
Fund Postdoctoral Fellowship (to C.M.D.-G.).
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EFFECT OF ANG II ON THE INSULIN SIGNALING PATHWAY IN ADIPOSE CELLS
Nicole Justine Moreno-Licona, Citlaly Gutierrez-Rodelo, Huguet Landa-Galván,  
Gabriela Karina Parra-Mercado, Judith Hernández-Aranda, and Jesus Alberto Olivares-Reyes
Laboratory of Signal Transduction, Department of Biochemistry, CINVESTAV-IPN, México City, México
In adipose tissue, insulin exerts a myriad of effects associated 
with the regulation of lipid and glucose metabolism, being 
responsible for maintaining energy balance. The decrease in 
the insulin response in adipose cells leads to an imbalance 
that is associated with various metabolic diseases. In this con-
text, studies performed in patients with metabolic syndrome 
showed that the levels of Angiotensin II (Ang II), an octapep-
tide generated by the renin- angiotensin system (RAS), are 
increased in adipose tissue; suggesting that, this hormone is 
involved in the pathogenesis of obesity and insulin resistance. 
However, the mechanism associated with Ang II actions on 
insulin signaling in fat cells is still unclear. Thus, our work is 
focused on demonstrating the regulatory mechanism that Ang 
II exerts in fat cells on insulin signaling in 3T3-L1 adipocytes 
and epididymal adipocytes isolated from mice. We found that 
in 3T3-L1 adipocytes, Ang II impairs insulin signaling at the 
level of the IR and Akt activation as well the insulin-induced 
glucose uptake. These inhibitory actions were associated with 
increased phosphorylation of the insulin receptor at serine 
residues. Interestingly, angiotensin II-induced serine phos-
phorylation of IRS was not detected; suggesting that angio-
tensin II-induced desensitization begins at the regulation of 
insulin receptor itself. PKC inhibition by BIM (a PKC inhibi-
tor) restored the inhibitory effect of angiotensin II on insulin-
stimulated tyrosine phosphorylation of IR, glucose uptake, 
and Akt inactivation. These results suggest that angiotensin II 
may lead to insulin resistance through PKC activation in 3T3-
L1 adipocytes. Finally, in adipose cells isolated from mouse 
epididymal tissue, we confirm the decrease in the insulin sign-
aling with the consequent reduction of the phosphorylation in 
proteins located downstream of the signaling cascade as Akt.
This work was supported by CONACYT grant 167673; 
Estímulo a la Investigación Médica “Miguel Aleman Valdes” 
2018 to J.A.O-R., and CONACYT-scholarship grant: 632503 
to NJM-L; 278067 to HL-G, and 296029 to GKP-M.
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CIRCADIAN DISRUPTION AS A RISK FACTOR FOR HIGH ADIPOSITY
Carolina Escobar
Departamento de Anatomía, Facultad de Medicina, Universidad Nacional Autónoma de México,  
Ciudad de México
Shift-work, frequent transmeridional traveling, shifted sleep 
time and light at night are conditions that lead to circadian 
disruption and loss of behavioral and physiological homeo-
stasis. Individual exposed constantly to such disruption are 
at risk to develop overweight and metabolic disturbance. In 
order to better understand the mechanisms that lead to the 
loss of homeostatic balance we have developed experimental 
models with rodents. A main effect observed with all models 
is an increased adiposity and dyslipidemia. We have observed 
that animals exposed to protocols of circadian disruption, 
shift their feeding schedules to the hours when they are forced 
to be awake, even when this timing is in conflict with the light-
dark cycle. Therefore, we have exposed animals to restricted 
feeding schedules of 12 h fasting – 12h food. When food was 
scheduled to the normal activity phase, which is night for ro-
dents, the feeding schedule restored circadian rhythmicity and 
prevented overweight and dyslipidemia. However, when food 
was scheduled out of phase from the normal light-dark cycle, 
it triggered have deleterious effects on metabolism and body 
weight.
We will present experimental evidence of deleterious ef-
fects of disrupted circadian rhythms on metabolism and bod-
yweight and will point out the relevance of the timing of food 
intake. We will further discuss the benefits and limitations of 
feeding schedules to ameliorate the metabolic burden in shift 
workers and other individuals affected by circadian disrup-
tion.




AAV-MEDIATED INHIBITION OF GLRX1 IN MOUSE SKELETAL MUSCLE:  
A THERAPEUTIC APPROACH TO IMPROVE ISCHEMIC LIMB
Beatriz Ferran1, Toyokazu Kimura1,3, Yuko Tsukahara1, David Pimentel2, Markus Michael 
Bachschmid1, and Reiko Matsui1
1Vascular Biology Section and 2Cardiology, Whitaker Cardiovascular Institute, Boston University School of 
Medicine, USA; 3Cardiovascular Medicine, National Defense Medical College, Japan
Diabetes is a critical risk factor for the development of pe-
ripheral artery disease. Patients with type-2 diabetes have im-
paired blood flow recovery in response to ischemia compared 
with non-diabetic subjects. We reported that glutaredoxin-1 
(Glrx) deletion promotes vascularization via HIF-1α stabiliza-
tion after hindlimb ischemia, indicating that Glrx acts as an 
anti-angiogenic enzyme, which also regulates redox signaling. 
Adeno-associated viruses (AAVs) have been particularly en-
ticing for human gene therapy due to their transduction ef-
ficiency, safety, and stable gene expression. The primary goal 
of this project was to inhibit Glrx protein levels specifically 
in the skeletal muscle using AAVs. HEK293T cells were co-
transfected using a helper-free AAV system, and a bicistronic 
expression system encoding a short hairpin RNA (shRNA) 
against Glrx or a control shRNA sequence, and mVenus, a 
fluorescent protein used as reporter. AAVs were purified from 
medium and cell lysates by polyethylene glycol precipitation, 
aqueous two-phase partitioning, and an iodixanol gradient. 
Titers and purity of AAVs were determined by qPCR and sil-
ver staining, respectively. C2C12 cells and C57Bl/6 mice were 
used to test the viral preparations. The optimized protocol 
yielded viral preparations with titers of 1010-1011 viral genome 
copies per µL, and more than 90% of purity, suitable for in vivo 
studies. Transduced C2C12 cells exhibited a ~75% decrease in 
Glrx expression and protein levels, four days after infection. 
Intramuscular injection of AAV6 in the mouse gastrocnemius 
efficiently transduced the reporter mVenus, which was not 
detected in heart, liver, or the gastrocnemius from the non- 
injected limb. Three weeks post injection, Glrx protein levels 
remained unchanged, but after six weeks, Glrx mRNA and 
protein levels decreased by 80% and 50%, respectively. Suc-
cessful inhibition of Glrx in the medial thigh constitutes the 
first step in our strategy for improving blood flow recovery 
after hindlimb ischemia in diabetic mice.
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HIGH-INTENSITY INTERVAL TRAINING REDUCTION OF CROWN-LIKE 
STRUCTURES IN ADIPOSE TISSUE
García-Flores Estefania1, Barajas-Martínez Antonio2, Guzmán-Uribe Carlos2, Navarro Luz2, and 
Martínez-Vargas Marina1,2
1Escuela Militar de Graduados de Sanidad, SEDENA; 2Facultad de Medicina, UNAM, Mexico City
Obese adipose tissue is infiltrated by macrophages where 
they surround dead adipocytes resulting in a characteristic 
morphological crown-like structure (CLS). In the adipose 
tissue macrophages release cytokines and constitute part of 
the mechanisms by which obesity results in an increased car-
diovascular and type 2 diabetes risk. Exercise, recommended 
for the treatment of obesity and reduction of the metabolic 
risk, reduces the presence of CLS in adipose tissue. Recently 
high-intensity interval training (HIIT) has emerged as a more 
efficient alternative to traditional moderate-intensity continu-
ous training (MICT). Thus, we aimed to compare the amount 
of CLS reduction in the adipose tissue of rats with metabolic 
syndrome that underwent these exercise protocols. Young 
adult male Wistar rats were housed in standard conditions 
and divided into four groups. First group was control and had 
food and water ad libitum. The three remaining groups had 
water replaced by a 20% sucrose solution. The four groups re-
ceived this treatment for 12 weeks after which the sucrose fed 
groups underwent MICT, HIIT or no exercise for 8 weeks. At 
the endpoint metabolic syndrome measurements were taken 
and adipose tissue was collected for histological examina-
tion. Hematoxylin and eosin, and immunohistochemistry for 
F4/80 macrophage marker were performed to observe CLS. 
Obtained images were analyzed with FIJI software for adipo-
cyte size, CLS count and immunohistochemical staining. Su-
crose fed group adipose tissue exhibited large adipocytes and 
abundant F4/80 staining was visible while control group had 
scarce staining and smaller mean adipocyte size. Both exercise 
groups had a comparable decrease of the macrophage stain-
ing, and adipocyte size that was correlated with assessment of 
metabolic syndrome. HIIT appears to be as effective as MICT 
for the reduction of adipocyte size and macrophage infiltra-
tion of the adipose tissue and this reduction is accompanied 
with an improvement of metabolic syndrome indicators.
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PHARMACOLOGICAL MODULATION OF OSTEOCALCIN LEVELS: OPPOSITE 
METABOLIC EFFECTS OF WARFARIN AND ALENDRONATE
Zhelyazkova-Savova Maria and Gancheva Silvia
Department of Pharmacology and Clinical Pharmacology and Therapy, Varna Medical University, Bulgaria
Recent experimental evidence implicates the bone-derived vi-
tamin K-dependent protein osteocalcin (OC) in regulation of 
energy metabolism. Undercarboxylated osteocalcin (ucOC), 
released in blood during bone resorption, is postulated to 
stimulate insulin secretion and to increase insulin sensitivity. 
These findings raise variety of questions, including pharmaco-
logical in nature. The present work aimed at studying whether 
pharmacological modulation of ucOC serum levels could 
produce metabolic changes. Thus, we examined the effects of 
two drugs of wide clinical use: (i) the vitamin K antagonist 
warfarin and (ii) the anti-resorptive anti-osteoporotic bis-
phosphonate drug alendronate. Four groups of male rats were 
treated for 4-6 weeks with: (i) high dose of warfarin by oral 
gavage plus a protective dose of vitamin K1 to prevent bleed-
ing; (ii) alendronate by s.c. injection; and (iii-iv) vehicles for 
each treatment. At the end of the experiments insulin-toler-
ance test was performed by measuring blood sugar at 0, 30, 60 
and 90 minutes after an i.p. insulin injection. Adipose index 
was determined as the retroperitoneal adipose mass to body 
weight ratio. Serum ucOC was measured by an ELISA kit. 
Chronic treatment with warfarin caused a pronounced eleva-
tion of ucOC. This was associated with borderline decrease in 
blood sugar and improvement of insulin sensitivity. The adi-
pose index decreased significantly. Chronic administration of 
alendronate resulted in significant reduction of ucOC. Blood 
glucose was elevated and insulin sensitivity was impaired. The 
increase of adipose index did not reach statistical significance. 
In effect, warfarin and alendronate induced opposite changes 
in serum ucOC levels and these were accompanied by corre-
sponding alterations in markers of energy metabolism. Cau-
tion is needed in the clinical interpretation of these findings. 
Studies in humans are limited and the available data are in-
consistent.
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THE EFFECT OF SELECTED INCRETIN DRUGS ON ADMA METABOLISM IN 
CARDIOVASCULAR SYSTEM OF FRUCTOSE-FED RATS
Anna Warpas, Grażyna Wójcicka, Dagna Siedlecka, Eva Krzewicka-Romaniuk,  and  
Jerzy Bełtowski 
Department of Pathophysiology, Medical University of Lublin, Lublin, Poland
High level of circulating asymmetric dimethylarginine 
(ADMA), an endogenous inhibitor of nitric oxide (NO) syn-
thesis, is a risk factor for endothelial dysfunction and cardio-
vascular disease (CVD) development. ADMA is synthesized 
by protein-N-methyltransferase 1 (PRMT1) and catalysed by 
dimethylarginine dimethylaminohydrolases (DDAH1,2). The 
major route of ADMA elimination from circulation is its re-
nal uptake and degradation. The tight enzymatic control of 
ADMA metabolism may be dysregulated in insulin resistance 
and diabetes. Therefore, the aim of this study was to evalu-
ate whether dipeptydylopepydase-4 inhibitor (sitagliptin) 
and glucagonlike peptide 1 analogue (exenatide) may affect 
ADMA metabolism in kidney and heart of rats with fructose 
induced metabolic syndrome.
Normal (CON) and fructose-fed (FRU) rats were treated 
for 4 weeks with sitagliptin (S) (5.0 and 10 mg/kg p.o) or 
with exenatide (E) (5 and 10 µg/kg, s.c.). The activity of tissue 
DDAH was measured spectrophotometrically. The concen-
tration of plasma NO, ADMA and tissue DDAH1, DDAH2, 
PRMT1 protein were measured by enzyme immunoassay 
technique. Myocardial DDAH1 and DDAH2 expressions were 
assessed by RT-PCR analyses.
The significant increase of ADMA (+27,0%) and decrease 
of NO (-57,4%) concentrations were found in plasma of fruc-
tose-fed (FRU) rats vs control (CON). Exenatide administra-
tion reduced plasma ADMA level by 39,7% (FRU+E5) and 
38,5% (FRU+E10) vs FRU, respectively. Both, sitagliptin and 
exenatide treatment caused significant increase in NO concen-
tration: FRU+S5 (+111,7%); FRU+S10 (+100,9%); FRU+E5 
(+97,1%) and FRU+E10 (+100,9%) vs FRU. In the kidney, 
there was significant increase in DDAH activity after both, sit-
agliptin (+47,8%; FRU+S10) and exenatide (72,5+%; FRU+E5 
and +45,1%; FRU+E10) treatment vs FRU. By contrast, the sit-
agliptin treatment resulted in myocardial DDAH activity re-
duction (-66%; FRU+S5 vs FRU), whereas exenatide increased 
the PRMT1 mass (+60%) in FRU+E10 vs FRU. In fructose-fed 
rats, both sitagliptin and exenatide improve ADMA hydrolytic 
elimination in the kidney but have no beneficial effect on en-
zymatic control of its metabolism in the heart.
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IMPACT OF MATERNAL OVER-NUTRITION DURING PREGNANCY ON THE 
CIRCADIAN REGULATION OF CORE BODY TEMPERATURE IN LACTATING RABBITS
Erika Navarrete1, Andrea Díaz-Villaseñor1, Pamela E. Vega-Ruíz1, Georgina Díaz H.1,  
Ana María Salazar1, Rodrigo Montúfar-Chaveznava2, Patricia Ostrosky-Wegman1, and  
Ivette Caldelas1
1Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México and  
2Facultad de Ingeniería, Universidad Nacional Autónoma de México, Ciudad de México, México
Metabolic parameters ranging from circulating nutrient levels 
and substrate utilization to energy expenditure and thermo-
genesis are temporally modulated by the circadian timing sys-
tem. During critical embryonic developmental periods, ma-
ternal over-nutrition, could alter key elements in different tis-
sues associated with the generation of circadian rhythmicity, 
compromising normal circadian rhythmicity at birth. To ad-
dress this issue, we used a rabbit model to determine whether 
maternal over-nutrition leads to alterations in the develop-
ment of circadian rhythmicity at physiological and behavio-
ral levels in the offspring. For this, female rabbits were fed a 
standard diet (SD) or high-fat and carbohydrate diet (HFCD) 
before mating and during gestation. At birth, newborn rabbits 
were maintained under a light: dark cycle and nursed by foster 
mothers (that were fed SD). From lactation to weaning, their 
core body temperature and gross locomotor activity were con-
tinuously recorded through telemetry, and daily measurement 
of body weight and the amount of milk ingested by the pups 
was carried out. At the end of lactation, a group of animals was 
killed, and blood and tissue samples, including brown adipose 
tissue (BAT) and white adipose tissue (WAT) samples, were 
obtained for determining the levels of uncoupling protein-1 
(UCP1) and cell death-inducing DNA fragmentation factor-
like effector A (CIDEA).
HFCD pups exhibited conspicuous differences in the de-
velopment of the daily rhythm of temperature and locomotor 
activity compared to the SD pups, including a significant in-
crease in the daily mean core temperature, changes in the time 
when temperature or activity remains above the average, shifts 
in the acrophase, decrease in the duration and intensity of the 
anticipatory component, and changes in the most energetic 
components of the rhythms. HFCD pups exhibited a signifi-
cant increase in BAT thermogenesis markers and a decrease 
of these markers in WAT, indicating less heat generation by 
brown adipocytes and alterations in the browning process. 
These results clearly indicate that maternal over-nutrition al-
ters offspring homeostatic and chronostatic regulation at the 
physiological and behavioral levels. Further studies are needed 
to accurately determine whether alterations in environmental 
factor during gestation are associated with the changes in the 
organization of the circadian system of the progeny.
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INFLAMMATORY MARKERS IN THE SERUM OF ADULT SUBJECTS WITH 22Q11.2 
DELETION SYNDROME
Tarani Luigi1, Petrella Carla2, Carito Valentina2, Ferraguti Giampiero3, Micangeli Ginevra13, 
Ceccanti Mauro4, and Fiore Marco2
1Department of Pediatrics, Child Neurology, Sapienza University Hospital of Rome; 2Institute of Cell Biology 
and Neurobiology, National Research Council (IBCN-CNR), Rome; 3Department of Cellular Biotechnologies and 
Hematology, and 4Centro Riferimento Alcologico Regione Lazio, Sapienza University of Rome, Italy
DiGeorge syndrome (1,2), also known as 22q11.2 deletion 
syndrome, is a syndrome caused by the deletion of a small seg-
ment of chromosome 22. While the symptoms can vary, they 
often include congenital cardiovascular problems, specific fa-
cial features, frequent infections, developmental delay, learn-
ing problems and cleft palate. Associated conditions include 
kidney problems, significant feeding and metabolic problems, 
hearing loss and autoimmune disorders. DiGeorge syndrome 
occurs in about 1 in 4,000 people. Since nerve growth factor 
(NGF) and brain-derived neurotrophic factor (BDNF) are 
known to play subtle roles in the regulation of oxidative, car-
diometabolic and immune physiological related events (3–5), 
in this study we evaluated NGF and BDNF serum levels of and 
some markers of oxidative stress in subjects with DiGeorge 
syndrome. The sample population consisted of 14 men and 4 
women diagnosed by both a geneticist and a molecular analy-
sis. Twenty healthy men and 11 healthy women were included 
in the study as controls. Venous blood samples were collected 
and NGF and BDNF levels were measured by ELISA assay. The 
mean NGF serum levels of DiGeorge syndrome patients were 
significantly lower compared to controls in absence of gender 
differences. However, BDNF serum levels were not significant 
altered compared to controls. Oxidative stress was analyzed as 
free oxygen radicals defense (FORD) and free oxygen radicals 
test (FORT) in association with a panel of 8 cytokines whose 
expression levels are strongly influenced by NGF/BDNF. Data 
show that in DiGeorge syndrome serum Interleukin (IL)-1β, 
IL-2, IL-6 and IL-12 were significantly reduced. Quite inter-
estingly serum FORT in DiGeorge syndrome was potentiated 
but only in those subjects under treatment for mood regula-
tors. Our study suggests a potential role of the NGF pathway 
as marker for appropriate treatment of immune, metabolic 
and central nervous systems trophic disconnections in Di-
George syndrome.
1. Morsheimer M, Brown Whitehorn TF, Heimall J, Sullivan 
KE. The immune deficiency of chromosome 22q11.2 de-
letion syndrome. Am J Med Genet A 2017;173:2366–72. 
doi:10.1002/ajmg.a.38319.
2. Adams DJ, Clark DA. Common genetic and epigenet-
ic syndromes. Pediatr Clin North Am 2015;62:411–26. 
doi:10.1016/j.pcl.2014.11.005.
3. Carito V, Ceccanti M, Tarani L, Ferraguti G, N. Chaldakov 
G, Fiore M. Neurotrophins’ Modulation by Olive Polyphe-
nols. Curr Med Chem 2016;23:3189–97. doi:10.2174/0929
867323666160627104022.
4. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova 
MG, Antonelli A, et al. Neurotrophin presence in human 
coronary atherosclerosis and metabolic syndrome: A role 
for NGF and BDNF in cardiovascular disease? Prog Brain 
Res 2004;. doi:10.1016/S0079-6123(03)46018-4.
5. Yanev, Stanislav, Aloe L, Fiore M, Chaldakov GN. Neu-
rotrophic and metabotrophic potential of nerve growth 
factor and brain-derived neurotrophic factor: Linking car-




WAIST-TO-HEIGHT RATIO, RELATIVE FAT MASS AND CARDIOMETABOLIC 
FACTORS IN PATIENTS OF A YUCATAN TERTIARY CLINIC
Ham-Alvarez Katia1, Gutierrez-Solis Ana Ligia2, Lugo-Gomez Roberto2, Garcia-Perez Rodrigo1, 
Herrera-Escalante Sarahi2, and Pacheco-Pantoja Elda1
1Escuela de Medicina, Universidad Anáhuac Mayab; 2Hospital Regional de Alta Especialidad de la Península  
de Yucatán, Mexico
It is widely accepted that body composition is an essential 
part of the check up for preventing complications associated 
to the excess of adipose tissue. According to the Mexican 
Health Survey (ENSANUT-MC-2016), the country south-
eastern shows one of the highest rates of overweight and as-
sociated morbidities (i.e. diabetes). In this study we evaluated 
the Waist/Height ratio (W/Hr) as a better indicator, applicable 
to any population, than body mass index (BMI) for cardio-
metabolic risk. Also, we used a new Relative Fat Mass (RFM) 
linear equation, as a tool to estimate whole-body fat percent-
age that has high correlation with DXA in adult population 
of Mexican- Americans. The present study is cross-sectional, 
with 100 participants (76 women and 24 men) from a tertiary 
clinic, who were surveyed for lifestyle, body composition and 
serum biochemical determinations (glucose, triglycerides, to-
tal cholesterol (TC), cholesterol-HDL, cholesterol-LDL, urea, 
creatinine, insulin) and atherogenic index. The mean age 
was 48.03±10.76 years old, and 54% fulfilled the criteria (ac-
cording to NCEP- ATPIII) for metabolic syndrome (MetS). 
We performed correlation analyses of W/Hr and BMI with 
the main indicators for MetS and the results showed positive 
significant correlation with RFM (p<0.001, for both indexes), 
diastolic pressure (DBP) (p=0.013, p=0.021, respectively), in-
sulin (p=0.002, p<0.001, respectively), and only W/Hr showed 
significant positive correlation with glycaemia (p=0.012). For 
mean comparisons, we split the sample in two groups of W/Hr 
(<0.6 and >0.6, n=48 and n=52, respectively), and two groups 
of BMI (<25 and >25, n=16 and n=84, respectively). The re-
sults for W/Hr>0.6 were higher glycaemia (p=0.006), insulin 
(p=0.006), DBP (p=0.009), and RFM (p<0.001). For BMI>25, 
higher insulin (p=0.002), TC (p=0.009), LDL (p=0.012), tri-
glycerides (p=0.024) and RFM (p<0.001). In conclusion, W/
Hr and BMI had significant association with markers of MetS, 
however only W/Hr was consistently associated with glycae-
mia, and both with, at least, one dyslipidemia indicator.
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AQP7 REGULATION BY GLUCOCORTICOIDS IN WHITE AND BROWN ADIPOCYTES
Álvarez-Pérez Mariana Frida1, González-Dávalos Laura1, Quesada-López Tania2, Piña Enrique3, 
Villarroya Francesc2, and Mora Ofelia1
1Facultad de Estudios Superiores Cuautitlán, UNAM;2Institute of Biomedicine, UB; 3Facultad de Medicina, UNAM.
The regulation by glucocorticoid hormones (GCs) is essential 
in biological processes such as development, immunity and 
energy metabolism. Aquaporin 7 (AQP7) is the primary glyc-
erol transporter in white (WAT) and brown (BAT) adipose tis-
sues. With the aim to compare the action of cortisone over the 
expression of AQP7, and to test if there were differences be-
tween white adipocytes (WA) and brown adipocytes (BA), two 
different primary cultures from CD-1 mice were performed. 
Brown adipose tissue from 1-day old mice was dissected and 
digested for precursors’ extraction and 21-day old mice sub-
cutaneous WAT was dissected to obtain white precursors. All 
cell culture assays were differentiated into white or brown adi-
pocytes and, once differentiated, cortisone response was char-
acterized (0.1, 1 and 10 M), at 5 different times (0, 5, 10, 15, 20 
minutes and 48 hours). In addition, the human SGBS cell line 
was employed; these precursor cells were differentiated into 
white adipocytes in order to characterize potential differences 
between mice and human cells. Gene expression was meas-
ured by qPCR and the relative abundance of specific mRNAs 
was calculated using the 2-ΔΔCT method. There were immedi-
ate and quantitatively important actions of cortisone over the 
expression of AQP7 in murine and human adipocytes. Short-
term response (minutes) of cortisone treatment resulted in 
AQP7 mRNA overexpression in white and brown differenti-
ated adipocytes (between 1.5 and 6 fold). Conversely, long-
term response (hours or days) resulted in decreased mRNA 
expression. The effects observed on AQP7 mRNA expression 
upon cortisone treatment in brown and white differentiated 
adipocytes were concordant with those observed for glycerol 
kinase mRNA and 11β-hydroxysteroid dehydrogenase type 1 
mRNA. The regulatory pathways in the distinct adipose de-
pots-derived cells should be better characterized in order to 
clarify the role of GCs on aquaporins and its relevance in the 
development of metabolic diseases.
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DNA METHYLATION DETERMINE ADIPOGENIC POTENTIAL OF DENTAL  
TISSUE-DERIVED STEM CELLS
Coral-Sosa Abel3, Rodas-Junco Beatriz Adriana1, Peñaloza-Cuevas Ricardo2,  
Aguilar- Ayala Fernando2, Zepeda-Pedreguera Alejandro3, Nic-Can Geovanny Iran1,2
1CONACYT-Facultad de Ingeniería Química, Universidad Autónoma de Yucatán (UADY); 2Laboratorio 
Translacional de Células Troncales-Facultad de Odontología, UADY; 3Facultad de Ingeniería Química,  
UADY, Mexico
Obesity is a rising public health problem related to develop 
type 2 diabetes mellitus, cardiovascular diseases and cancer. 
With adipose precursors found outside of adipose depots 
(muscle, bone marrow, pericardium and others) it is clear that 
its expansion due to obesity might have a negative impact on 
human health. Therefore, the characterization of adipogenic 
commitment among different adipocytes depots requires fur-
ther research.
At like that human dental tissue-derived mesenchymal stem 
cells (hDT-MSCs), a subset of adipocytes originates from 
neural crest cells; therefore we reasoned that using these mes-
enchymal stem cells (MSCs) might be an entry point to un-
derstand the molecular mechanisms governing adipogenesis. 
MSC adipogenesis is quite complex and their full transcrip-
tional control remains unclear. DNA methylation is a crucial 
mechanism in the regulation of gene expression and is nec-
essary for controlling stem cell differentiation. But its contri-
bution in the establishment of final cell fate decision is still 
unclear. Therefore, the main goal of this study was to identify 
whether DNA methylation patterns between two cell lines of 
hDT-MSCs influences their cell plasticity. In the present study, 
we compared the morphological characteristics and the adi-
pogenic differentiation of hDT-MSCs such as periodontal lig-
ament stem cells (PLSCs) and dental pulp stem cells (DPSCs). 
We found that these cells displayed important differences in 
their adipogenic differentiation capacity. By using gene expres-
sion analysis, we found that PPARγ, a master transcriptional 
adipogenic factor, and DNMT1, a major DNA methyltrans-
ferase, was down- and upregulated in DPSCs. Moreover, in or-
der to know the DNA methylation status of several adipogenic 
genes among different cell lines, we used DNA methylation 
database and bioinformatic tools to correlate DNA methyla-
tion and adipogenesis potential of hDT-MSCs, for subsequent 
DNA bisulfite sequencing analysis. Together, these results will 
be leading to determine the role of DNA methylation in the 
adipogenic potential of hDT-MSCs.
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PERIODONTAL STEM CELLS AS STUDY MODEL FOR ADIPOGENESIS
Erick Pérez-Argueta1,2, Ricardo Peñaloza-Cuevas1, Fernando Javier Aguilar-Ayala1,  
Rafael Rojas-Herrera2, Geovanny Irán Nic-Can1,2 and Beatriz Adriana Rodas-Junco1,2*
1Translational Laboratory of Stem Cells of the Oral Cavity, Faculty of Dentistry, UADY;  
2Faculty of Chemistry Engineering, UADY. *beatriz.rodas@correo.uady.mx
Adipogenesis consists of two stages; the first is designated as 
“determination” which is characterized by the commitment of 
a pluripotent stem cell (SC) to the adipogenic lineage, while 
the second stage is called “terminal differentiation”, where the 
pre-adipocytes acquire the phenotype of a mature adipocyte. 
Currently, the in vitro models used to study adipogenesis are 
essential to understand the molecular mechanisms involved 
in this process and even though terminal differentiation has 
been studied extensively in the 3T3- L1/F442A lines, there 
are few reports focused on studying the determination stage. 
The objective of this work is to establish an in vitro model that 
allows the analysis of adipogenic differentiation through the 
culture of stem cells derived from the periodontal ligament 
(PLSC). For this, the periodontal ligament of a third molar 
from a male patient with 18 years old was obtained previous 
informed consent. Afterwards, the cells were isolated by the 
explant method. Subsequently, the characterization of the 
PLSD was performed. For adipogenic induction, the cells were 
seeded in multi-well plates and incubated under controlled 
conditions for 21 days. The identification of lipid droplets in 
the cells was done by staining with red oil and microscopic 
observation. The characterization of the PLSCs showed mor-
phology like fibroblasts and clonogenic populations, as well as 
the expression of pluripotency markers. The kinetic param-
eters of the in vitro culture suggest that their growth rate is 
high and that they maintain their viability during the culture 
period. On the other hand, a positive response to adipogenic 
differentiation was detected since the microscopic examina-
tion showed the presence of lipid vacuoles. In conclusion, the 
CTLP have a great cellular plasticity towards the adipogenic 
lineage which would allow to realize studies about the molec-
ular mechanisms involved during the process of adipogenesis.
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MECHANISM OF THE ANTI-DIABETIC ACTIVITY OF TERMINALIA ARGENTEA 
(COMBRETACEA) IN TYPE 2 DIABETIC MICE
Ulrich Carlos Mbiakop1, José Hugo de Souza Gomes2, Maria Aparecida Vieira3,  
Virgínia Soares Lemos3, Fernão Castro Braga2, and Steyner Cortes1
1Department of Pharmacology, ICB –UFMG; 2Department of Pharmaceutical Sciences, Faculty of Pharmacy – 
UFMG; 3Department of Physiology and Biophysics, ICB-UFMG, Belo Horizonte, Brazil
The present study aimed at investigating the potential anti-
diabetic effect of Terminalia argentea. The crude ethanolic 
extract (CEE) from the leaves of T. argentea, its ethyl acetate 
(EAF) and hydro-methanolic (HMF) fractions were screened 
for the inhibition of α-glucosidase, α-amylase, and lipase ac-
tivities, as well as on oral starch tolerance (OSTT) and hy-
poglycemic tests. T2DM was induced in male Swiss mice by 
intraperitoneal injection of nicotinamide (130 mg/kg) plus 
streptozotocin (150 mg/kg) two weeks after daily addition 
of fructose (10%) in drinking water. Four weeks later, mice 
with blood glucose level superior to 200 mg/dL started treat-
ment with CEE and EAF (100 mg/kg/per day) by gavage for 
28 days. After the treatment, the oral glucose tolerance test 
(OGTT) was performed. Serum parameters such as HBA1c, 
glucose, total cholesterol (TC), triglyceride (TG), and uric 
acid were measured. Glucose and creatinine were also meas-
ured in the urine. Serum alanine transaminase (ALT) and as-
partate transaminase (AST) were also measured to assess liver 
function. CEE, EAF and HMF concentration-dependently 
inhibited the activity of α- glucosidase (pIC50= 5.46±0.03, 
5.76±0.05, and 5.73±0.03, respectively), α-amylase (pIC50= 
4.15±0.18.4.77±0.20, and 4.06±0.16, respectively), and lipase 
(pIC50= 3.97±0.12, 3.87±0.04, 3.67±0.14, respectively). Blood 
glucose was significantly reduced by oral administration of 
100 mg/kg CEE, EAF, and HMF on OSTT, while only CEE 
significantly reduced glycemia after 1 hour on the hypogly-
cemic test. In T2DM mice, CEE and EAF improved glucose 
tolerance, significantly reduced blood glucose, HBA1c, uric 
acid, and creatinine, ALT, AST, TC, and TG levels. However, 
they did not change urine glucose and creatinine levels. The 
present results demonstrate that Terminalia argentea has an 
anti- diabetic activity with a significant effect on metabolic 
and liver parameters. Inhibition of α- glucosidase contributes 
to the mechanism of action of T. argentea.
.
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CHARACTERIZATION OF ADIPOSE TISSUE BY BIOPHOTONICS TECHNIQUES
Guadalupe Donjuán-Loredo1, Ricardo Espinosa-Tanguma1, Roberto Salgado-Delgado2, 
Francisco Javier González3 and Miguel Ramírez-Elías2
1Facultad de Medicina; 2Facultad de Ciencias and 3Laboratorio Nacional de Ciencia y Tecnología de Terahertz, 
UASLP, Mexico
Recently, Biophotonics techniques have emerged as an alter-
native tool in the analysis of biological tissues. In this work 
we propose the use of Raman spectroscopy (RS) and infrared 
thermography (IRT) to characterize spectral differences in 
adipose tissue of control, diabetic and obese rats. The main ad-
vantage of using RS combined with IRT in adipose tissue lies 
in the fact that these two techniques provide complementary 
information. RS provides information on changes in the mo-
lecular structure of the adipose tissue and IRT detect changes 
in the temperature related to energy metabolism of adipose 
tissue. To our knowledge, there is not published work that 
refers to the characterization of adipose tissue combining RS 
and IRT on rat model. In our work, RS and IRT of three differ-
ent groups of rats (control, obese, type I diabetes) was evalu-
ated. Before sacrifice, subjects were examined using an infra-
red camera to know the exact temperature of adipose tissue at 
the same anatomical location. After animals were euthanized, 
adipose tissue samples were extracted, and the Raman spec-
tra were obtained. The RS data were analyzed using principal 
component analysis (PCA) and we find the first two principal 
components provide information to discriminate between the 
three groups without the need of a priori information, only 
based on spectral features of each group. IRT results show an 
increase in temperature in obese group (temperature average 
of 35.9°C) and a decrease in type 1 diabetes group (tempera-
ture average of 32.5°C) relative to controls. In conclusion, the 
results show that RS combined with PCA is relatively simple, 
fast and can be used in the characterization of adipose tissue. 
Thermal imaging showed a specific thermal behavior of the 
adipose tissue in obese rats and may also be used as a non- 




FTO GENE VARIATION: SNP RS1421085, RS8057044, RS9939609 IN MEXICAN 
MAYAN CHILDREN WITH OBESITY OR OVERWEIGHT
González-Herrera Lizbeth1, Pérez-Mendoza Gerardo1, Lopez-González María José2,  
Pinto-Escalante  Doris1, Garcia-Escalante Maria Guadalupe1, and Rubì-Castellanos Rodrigo1
1Laboratorio de Genética. Centro de Investigaciones Regionales. Universidad Autónoma de Yucatán;  
S2DIMYGEN Laboratorio S.C.P., Mexico
Genetic variants within the FTO gene have been identified as 
risk factors with strong effects on variation of the human body 
mass and body composition. We evaluated the association 
of the FTO SNPs rs1421085, rs9939609, rs8057044, with the 
risk for obesity or overweight in Mexican school-aged chil-
dren with Mayan ethnicity, where childhood obesity is highly 
prevalent. We performed a case-control association study in-
cluding 318 children with obesity or overweight; and 303 chil-
dren with normal weight. FTO SNPs were genotyped using 
real- time PCR. FTO genetic variants’ effect on a child with 
overweight/obesity was assessed using a univariate and mul-
tivariate non-conditional logistic regression models adjusted 
for gender. Heterozygous genotype CT and allele C for FTO 
rs1421085 were associated with the highest genetic risk of hav-
ing childhood obesity (OR: 1.96, IC 1.26-3.05, p=0.003). Ad-
justing by gender, we obtained significant genetic associations’ 
specific to females or males. Heterozygous genotype AT (OR: 
1.94, IC 1.12- 3.63, p=0.023) and the risk allele A for rs9939609 
(OR: 1.58, IC 1-02-2.46, p=0.042), as well as rs1421085 het-
erozygous genotype CT (OR: 2.56, IC 1.36-4.79, p=0.003) and 
the risk allele C (OR: 1.98, IC 1.17-3.38.79, p=0.013); were sig-
nificantly associated with the genetic risk for obesity, only in 
females; whereas rs8057044, heterozygous genotype AG (OR: 
2.92, IC 1.04-8.20, p=0.035) and the risk allele A (OR: 2.28, 
IC 1.14-4.58,  p=0.021), were significantly associated with the 
genetic risk for overweight only in male children. The genetic 
effect of the FTO variants rs1421085, rs9939609, rs8057044 is 
specific about the gender on the genetic basis of obesity and 
overweight in Mayan school-aged children.
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ROLE OF CALPAINS ON GLUT4 TRAFFICKING IN ADIPOCYTES
Ana María Salazar1, Juan Pablo Pánico1, Jean Sabido-Barrera2, Rosa Ortiz Huidobro2,  
Marcia Hiriart2, and Patricia Ostrosky-Wegman1
1Instituto de Investigaciones Biomédicas, 2Instituto de Fisiología Celular, Universidad Nacional Autónoma de 
México (UNAM), Mexico
Calpains (CAPNs) are a family of calcium-dependent intra-
cellular proteases, and together with their endogenous inhibi-
tor, calpastatin, integrates the calpain system. The calpain sys-
tem is involved in several cellular processes, such as vesicular 
trafficking, apoptosis, cell migration and glucose homeostasis. 
Because CAPN1, CAPN2 and CAPN10 have been implicated 
in the glucose metabolism, in this work, we evaluated the role 
of these proteases in GLUT4 trafficking in adipocytes. First, 
we measured the presence of CAPN1, CAPN2 and CAPN10 
in retroperitoneal white adipose tissue, gastrocnemius muscle, 
liver, heart and pancreas of feeded adult mice, showing that 
the autolysis of CAPN1 and the expression of the isoforms 
of CAPN10 were higher in white adipose tissue, compared 
with the other tissues. In the 3T3-L1 cell line, we found that 
CAPN1, CAPN2 and CAPN10 were differentially expressed 
during adipocyte differentiation. Calpain activity increased 
after insulin stimulation in 3T3-L1 adipocytes using a fluoro-
genic calpain substrate peptide (tBoc- Leu-Met-CMAC). 
The inhibition of calpain activity with the calpain inhibitors 
AK275 or E64d reduced insulin-stimulated GLUT4 traffick-
ing in 3T3-L1 adipocytes. Moreover, calpain inhibition cor-
related with an increase of autolytic fragment of CAPN1 and 
increase of CAPN10 abundance, without changes in CAPN2. 
We found that CAPN10, but not CAPN1 or CAPN2 colocal-
ize with GLUT4 storage vesicles (GSVs) markers in 3T3-L1 
adipocytes. We confirmed the participation of CAPN10 in 
3T3-L1 adipocytes by generation of CAPN10 knockdown us-
ing a siRNA. CAPN10 knockdown did not induce changes on 
CAPN1 or CAPN2 expression. We observed that CAPN10 
knockdown alters GLUT4 trafficking, suggesting that 
CAPN10, but not CAPN1 and CAPN2, is related to GLUT4 




CALPAIN-10 PROTEASE REGULATES GLUT4 TRAFFICKING BY PROTEOLYTIC 
PROCESSING OF TUG IN ADIPOCYTES
Pablo Pánico1, Jean Sabido-Barrera2, Marco Meraz3, Rosa Ortiz-Huidobro2,  
PatriciaOstrosky-Wegman1, Marcia Hiriart2, and Ana María Salazar1
1Instituto de Investigaciones Biomédicas, 2Instituto de Fisiología Celular, 3Facultad de Química,  
Universidad Nacional Autónoma de México (UNAM), Mexico
Calpain-10 (CAPN10) is a protease implicated in the insu-
lin-induced trafficking of GLUT4. GLUT4 is retained in the 
Golgi matrix via the Tether containing a UBX domain for 
GLUT4 (TUG) protein. Insulin stimulation induces the pro-
teolytic processing of TUG, which leads to the translocation 
of GLUT4 to the cell membrane. In this study, we assessed 
whether TUG is a CAPN10 substrate in 3T3-L1 adipocytes. 
When the TUG proteolysis was analyzed in organs related to 
glucose homeostasis, we found different fragments of TUG in 
all tissues tested. In a cell-free system, we showed that TUG 
protein is cleavage by calpain proteases. As second approach, 
we evaluated the TUG proteolysis in the modulation of the 
calpain activity under conditions of stimulation with insulin, 
a Ca2+ ionophore or calpain inhibitors (ALLM, AK275 and E-
64d). We found that insulin-induced TUG proteolysis corre-
lated with the activation of calpains. In addition, we observed 
that TUG proteolysis was modulated by both Ca2+ ionophore 
and calpain inhibitors. Notably, calpain inhibitors prevented 
TUG cleavage, resulting in a decrease of insulin-stimulated 
glucose uptake and in impairment of GLUT4 trafficking. We 
confirmed that CAPN10 was implicated in TUG proteolysis 
by transient or stable knockdown of CAPN10, finding that 
calpain-10 knockdown prevent insulin-induced TUG proteol-
ysis without altering the phosphorylation of Akt. These results 
provide evidence that TUG protein is cleaved by CAPN10 to 
regulate GLUT4 trafficking Acknowledgements to CONA-
CYT 254305 and PAPIIT-UNAM IN201914.
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ARSENIC INCREASES LIPOGENESIS IN RETROPERITONEAL ADIPOSE TISSUE IN 
MICE FED HIGH-FAT DIET
Calderón-DuPont Diana1,4, Morán-Ramos Sofía2, Contreras Alejandra2,3,  
Chiu-Velázquez Luz María4, and Díaz-Villaseñor Andrea4
1Biomedical Sciences, UNAM; 2Unidad de Genómica de Poblaciones aplicada a la Salud, INMEGEN, México City, 
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Ambiental, Instituto de Investigaciones Biomédicas, UNAM, México City, México
Adipose tissue accumulates fat mainly in the form of triglyc-
erides through de novo lipogenesis and/or fatty acid re-esteri-
fication. Visceral adipose tissue accumulation has been associ-
ated with the development of metabolic diseases such as type 
2 diabetes mellitus.
High-calorie diets contribute to excessive triglyceride ac-
cumulation in adipocytes. In addition to this factor, some 
environmental contaminants have been classified as metab-
olism-disrupting chemicals that promote metabolic diseases. 
Arsenic, for example, has been proved to be diabetogenic. 
Nonetheless, little is known about its effects on adipose tis-
sue dysfunctionality in combination with high-fat diet (HFD). 
Therefore, the purpose of this study is to determine if arsenic 
favors triglycerides accumulation in different visceral adipose 
tissue pads predisposing to weight gain and if this effect in-
creases in combination with HFD. C57BL/6 male mice were 
fed low-fat diet or HFD for 8-weeks. Then, half of each group 
was exposed to arsenic (100 µg/L) in the drinking water for 
additionally 8 weeks, maintaining their same diet. Throughout 
the study, body weight, food and water intake were measured 
weekly. At the end, retroperitoneal and epididymal adipose 
tissues were collected to evaluate tissue weight, adipocytes 
area, triglyceride content, and mRNA of lipogenic genes. Mice 
exposed to arsenic had greater body weight gain than their 
counterpart without arsenic. Mice fed HFD and exposed to 
arsenic had greatest body weight gain, the largest adipocytes 
with the highest intracellular triglyceride content in retrop-
eritoneal adipose tissue. Interestingly, arsenic, regardless of 
the amount of fat in diet, increased the mRNA of the genes 
involved in de novo lipogenesis (SRBP-1c, ACC), in the esteri-
fication of fatty acids (DGAT1) and in adipogenesis (PPAR-γ) 
in retroperitoneal adipose tissue, while decreased them in 
epididymal adipose tissue. Our data suggest that arsenic fa-
vors triglyceride accumulation in retroperitoneal adipose tis-
sue by increasing lipogenesis and in combination with HFD 
increases the obesity phenotype.
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SILYMARIN IMPROVES THE METABOLIC OUTCOME OF OBESE RATS
Ximena Torres Castro1,2, Mara Alaide Guzmán Ruiz1,3, Abel Santamaría del Ángel4, and  
Anahí Chavarría Krauser1
1Unidad de Investigación en Medicina Experimental, Facultad de Medicina; 2Posgrado en Ciencias Biológicas; 
3Departamento de Fisiología, Facultad de Medicina, UNAM; 4Instituto Nacional de Neurología y Neurocirugía, 
SSA, Mexico
Obesity characterizes for the pathological increase in adi-
pose tissue, with hypertrophic adipocytes that secrete pro-
inflammatory cytokines and pro-oxidant factors that induce a 
chronic mild pro-inflammatory state. There are adverse meta-
bolic effects observed during obesity such as hyperglycemia, 
hyperinsulinemia, glucose intolerance insulin resistance, dys-
lipidemia, all of these eventually leading to the development of 
metabolic diseases and diabetes mellitus type 2. The explora-
tion of therapies aimed to counteract the metabolic effects of 
high-fat diets (HFD) has become a priority in western civili-
zations. Silymarin is a flavonoid mixture extracted from the 
Silybum marianum, known for its hepato-, neuro-, nephro- 
and cardio- protective properties, mediated by its anti-inflam-
matory and anti-oxidant effects. The present study aimed to 
evaluate if an intragastric (i.g.) administration of silymarin 
modulates the metabolic impairments observed in Wistar rats 
previously fed with HFD for 12 weeks. We observed that 14 
days of i.g. administration of silymarin significantly decreased 
glucose levels in obese rats, even when rats continued con-
suming the HFD, however, silymarin had no effects in body 
weight, nor changed the amount of adipose tissue.
Our results suggest that silymarin improves glucose metab-
olism during obesity in a body weight independent manner.
Acknowledgements: Ximena Torres-Castro is a master 
student from Programa de Maestría en Ciencias Biológicas, 
UNAM, and received fellowship CVU814501 from CONA-
CYT.
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SHORT TERM EFFECT OF EARLY POSTNATAL OVERNUTRITION IN 
TRANSCRIPTOME OF AXIS HYPOTHALAMUS-ADIPOSE TISSUE WISTAR RAT
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Elena Zambrano González2, Maria Elizabeth Tejero Barrera1, Enrique Hong Chong3, and  
Laura del Bosque Plata1
1National Institute of Genomic Medicine; 2National Institute of Medical Sciences and Nutrition “Salvador 
Zubirán”; 3Center of Research and Advanced Studies, Mexico; 4National Autonomous University of México. 
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Deregulation of the hypothalamus-adipose tissue axis has 
been reported in metabolic diseases. Recent reports in animal 
models with hypercaloric diet show changes in neurons that 
regulate behaviors of appetite and satiety, resulting in hyper-
phagia. However, alterations of the hypothalamus-adipose tis-
sue axis in early postnatal stages have not been fully described. 
Analyze the short-term effect of the EPO in the hypothala-
mus and adipose tissue transcriptome. Overnutrition model 
in Wistar rats by overlactation from day 3 to day 21 of life by 
litter size reduction method using pup male was generated; 
control (n=5) and overnutrition (n=5). Transcritome was ana-
lyzed by microarrays of expression (Ratgene ST 2.0, Affym-
etrix®), with a coverage of 28,407 transcripts. Quantification 
of glucose, cholesterol, insulin, triglycerides and leptin. The 
transcripts were analyzed with the cut-off points of log fold 
change and p-value (2, 0.05 respectively). The pathway analy-
sis was performed with the Ingenuity Pathway Analysis soft-
ware. Bioinformatic analysis was performed on the R statisti-
cal software, statistical analysis for phenotypic and biochemi-
cal parameters were analyzed in Graphpad Prism 6® software 
was applied Student t probe with p < 0.05. The data obtained 
shows overweight in treatment group in 21 days of life, and 
high concentration of triglycerides, glucose and serum leptin. 
Transcriptome analysis in hypothalamus showed 98 under-
expressed transcripts and 128 overexpressed. Furthermore the 
adipose tissue transcriptome showed 61 overexpressed and 
100 underexpressed transcripts. We show for the first time the 
effects of EPO in the hypothalamus and adipose tissue tran-
scriptomes to 21 days of life. EPO generates insulin resistance 
and dyslipidemia in the animal model. In hypothalamus de-
regulated pathways regulates lactation, inflammation, circa-
dian rhythms and leptin resistance. The deregulated pathways 
in adipose tissue were associated to inflammation, disorder of 
lipid metabolism and leptin resistance.
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NGF INCREASES GLUCOSE UPTAKE IN PANCREATIC Β CELLS AND ADIPOSE TISSUE 
OF 20-DAY POSTNATAL RATS
Samario Román Jazmín Selene, Sanchez Maldonado Juan Pablo, Ortiz Huidobro Rosa Isela, 
Sabido Barrera Jean Imanol, Larque Velázquez Carlos Alfonso, and Hiriart Urdanivia Marcia
Department of Cognitive Neurosciences, Institute of Cellular Physiology, UNAM, Mexico
Around the weaning stage, in which glucose and insulin levels 
are high, rats show physiological resistance to insulin1. Insulin 
resistance (IR) results in the disruption of the insulin sign-
aling pathway; in which, decreases GLUT4 translocation to 
the membrane in adipose and muscular tissue. On the other 
hand, in an analysis of rats pancreatic β cell transcriptome, 
reported that GLUT2 is diminished in postnatal day 20 (P20) 
when compared with adults2. This observation could be relat-
ed to the decrease in insulin secretion stimulated by glucose, 
in animals at this age. At the weaning stage, pancreatic β cells 
and adipocytes are exposed to different factors that promote 
maturation of the cells. Among them, the change from high-
fat breast milk to a high carbohydrate diet, as well as growth 
factors, such as nerve growth factor (NGF). Both, white adi-
pose tissue and pancreatic β cells secrete NGF and express his 
receptors. This study aimed to investigate whether exposure 
to NGF in β cells of Wistar rats on the postnatal day 20 pro-
motes the translocation of GLUT2 to the plasma membrane, 
and establish whether glucose transport changes in this cells 
and also adipose tissue. From male Wistar rats of 20 days and 
adults, peripancreatic adipose tissue was isolated, and primary 
β cells cultured. We incubated β cells, and adipose tissue with 
NGF, and performed glucose uptake assays. We evaluated the 
expression of GLUT2 in pancreatic β cells, by immunofluores-
cence and Western Blot. After incubating the P20 cells with 
NGF, there was an increase in GLUT2-specific fluorescence in 
β cells. Moreover, we observed an increase in glucose uptake 
in both, pancreatic β cells and adipose tissue of 20-day post-
natal rats.
This study was supported by CONACYT: CB-253222, 
DGAPA-PAPIIT: IN210817
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RELEVANT ROLE OF SEX IN THE MOLECULAR MECHANISM OF PHYSIOLOGICAL 
INSULIN RESISTANCE IN ADIPOSE TISSUE
Ortiz-Huidobro Rosa Isela, Chávez-Maldonado Juan Pablo, Sabido-Barrera Jean, Larqué Carlos, 
Velasco Myrian, and Hiriart Marcia
Cognitive Neuroscience, Institute of Cellular Physiology, UNAM, Mexico
Insulin resistance is a condition in which the insulin-sensitive 
tissues cannot respond appropriately to the hormone. Adipose 
tissue is a crucial regulator in metabolic actions of insulin, 
and its dysregulation triggered this condition. Currently it has 
been suggested that sexual dimorphism in insulin sensitivity 
may be due to dimorphic differences in regulation of insulin 
signaling between males and females. We identified changes 
in the insulin signaling pathway in rat adipose tissue during 
postnatal development, around weaning.
We used male and female Wistar rats at postnatal day 20 
(p20) and adult rats (Ad). We analyzed fasting glucose and in-
sulin levels by a glucose tolerance test (GTT), and an insulin 
sensitivity test (ITT). We identified the phosphorylation of 
p-IRS-1 (Ser 1101), p-P70S6K1 (T389) and p-Akt (Ser 473) 
in gonadal adipose tissue, and the membrane distribution of 
GLUT4 in primary adipocytes. We performed insulin-stimu-
lated glucose uptake assays in gonadal adipose tissue.
We observed than blood glucose levels in GTT in p20 
male and female rats were higher than those of adults. Sys-
temic insulin response was lower in p20 males and females 
rats. P70S6K phosphorylation was higher in adipose tissue at 
p20 in males during fasting and postprandial state, while in 
females it is higher only in fasting. We observed IRS phos-
phorylation only at p20 in males and females during fasting. 
Akt phosphorylation is more significant in adipose tissue of 
males and females at p20 during fasting and postprandial, and 
less GLUT 4 was observed in the membrane of adipocytes 
in female rats after insulin stimulation. Insulin-stimulated 
glucose uptake in adipose tissue was lower in p20 in males 
and females, compared to adults. The over-activation of the 
P70S6K, at this developmental stadium, activates a mecha-
nism of down-regulation in the insulin signaling pathway in 
adipose tissue of p20 rats. This molecular mechanism presents 
sexual dimorphism.




SUGAR, METABOLIC SYNDROME AND LOW-GRADE INFLAMMATION:  
AN UNSWEET COMBINATION
Sanchez-Zamora YI, Myrian Velasco Torres, and Marcia Hiriart 
Institute of Cellular Physiology, UNAM, México
White adipose tissue (WAT) is an endocrine-paracrine organ 
that produces many hormones called adipokines, which can 
be involved in insulin resistance. The cytokine profile and cells 
type present in WAT depends on whether adipocytes are in 
a lean or obese state. In the first one, an anti-inflammatory 
profile (Th2) predominates, with the presence of alternatively 
activated macrophages or M2, eosinophils, innate lymphoid 
cells (ILC) and regulatory T and B lymphocytes (Tregs and 
Bregs). In obesity, the microenvironment in WAT is pro- in-
flammatory (Th1), macrophages express classical activation 
molecules (M1), secrete pro- inflammatory cytokines, neu-
trophils and natural killer cells (NK) are present. The WAT 
inflammation is characteristic of low-grade systemic inflam-
mation, a problem in metabolic syndrome (MS) and type 2 
diabetes mellitus (T2DM).
In Mexico the incidence of MS and T2DM is high, and it is 
essential for public health to evaluate the common population 
habits related to the incidence of MS and T2DM such as the 
consumption of sugary beverages. Therefore, this work evalu-
ated the inflammatory cytokines and immune cells in the adi-
pose tissue under a metabolic syndrome (MS) rat model, in-
duced by 20% saccharose in drinking water administered for 
2 and 6 months. The treated rats show central obesity, hyper-
triglyceridemia, hyperinsulinemia, mildly increased systolic 
pressure and insulin resistance compared to their controls.
Circulating inflammatory cytokines, like IL-1β and TNFα, 
increased in all of the treated groups. In adipose tissue Tregs 
(TCR+FOXP3+) and M2 macrophages (F480+IL-10+) de-
creased, whereas M1 macrophages (F480+IL-10-) increased. 
This picture shows that sugar consumption can initiate a low-
grade inflammation in adipose tissue that contributes to insu-
lin resistance.
Acknowledgments to CONACyT CB-253222, PAPIIT 
UNAM IN210817 y 213114.
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ROLE OF ADAM 10 AND 17 IN THE RELEASE OF SOLUBLE INSULIN RECEPTOR
Jean Imanol Sabido Barrera, Rosa Isela Ortiz Huidobro, Myrian Velasco Torres,  
Carlos Alfonso Larqué Velázquez, and Marcia Hiriart Urdanivia 
Cognitive Neuroscience, Institute of Cellular Physiology, UNAM, Mexico
Many membrane receptors have a soluble form generated by 
the liberation of the extracellular domain from the plasmatic 
membrane. The release of receptors affects the interaction be-
tween ligand-receptor, the signaling, and consequently its bio-
logical activity. The primary mechanism of soluble receptor 
liberation is a proteolityc cleavage by a family of enzyme called 
A Desintegrin and Metalloproteases (ADAMs).
We and other have previously described a Soluble form of the 
Insulin Receptor (SIR), which increase their levels in plasma 
in diabetes and metabolic syndrome. In this context, ADAM 
10 and 17 have participated in the release of a variety of sol-
uble tyrosine kinase receptors. In this work, we investigated 
how the activity of ADAM 10 and 17 could mediate the SIR 
generation.
We measure the ADAM 10 and 17 levels by immunofluo-
rescence and western blot in adipose tissue of rats with meta-
bolic syndrome, induced by 20% sugar in the drinking water. 
Also, we analysed if the catalytic inhibition of both proteases 
participates in the SIR release in the supernatant medium of 
primary adipocytes culture after insulin stimulation.
We observed decrease in the immature ADAM 10 and 17 of 
rats with metabolic syndrome without changes in the mature 
form. Moreover, when we inhibited both metalloproteases, 
not the individual ones, we observed an attenuated SIR release 
after insulin stimulation, compared to controls. These results 
illustrate the critical role of ADAM 10 and 17 in the SIR gen-
eration in adipose tissue mediated by high insulin levels, but 
more experiments are needed to understand the SIR cleavage 
mechanism depending on this ADAMs.




POLYMORPHISMS OF PON1 IN INFANTILE POPULATION AS AN EARLY RISK 
FACTOR TO DEVELOP OBESITY
Pérez Mendoza Gerardo José1, Canto Herrera Thelma2, Puerto Rajón Karla Pamela1,  
Valencia Pacheco Guillermo3, and González Herrera Lizbeth1
1Laboratory of Genetics, 2Laboratory of Reproduction Biology, 3Laboratory of Hematology. Center of Regional 
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Obesity is a complex and multifactorial disease that begins in 
childhood and is characterized by an excess of body fat that is 
recognized as a health risk. Changes in the gene sequence of 
paraoxonase 1 (PON1) in obese children have been shown to 
be a potential marker of early development of obesity. PON1 
is an enzyme present in high density lipoproteins (HDL) with 
antioxidant activity, so it is attributed anti- atherogenic prop-
erties. The objective of this study was to determine the asso-
ciation of polymorphisms of paraoxonase 1 (PON1) - 108CT, 
Q192R and L55M in children with overweight, obesity and 
normal weight of Yucatán. We studied a sample of 647 chil-
dren from different public primary schools in Mérida, Yuca-
tán, stratified in 251 with obesity (OB), 85 over weight (OW) 
and 311 with normal weight (NW). DNA was obtained from 
peripheral blood and quantitative PCR was performed for 
the determination of the polymorphisms. The genotypic, al-
lelic and haplotype frequencies were determined and the most 
common polymorphism in the OB, OW and NW population 
was L55M, LL (72%, 74% and 70% respectively), L allele (84%) 
and the LRC haplotype (35%, 30% and 37% respectively. The 
genotype CT of -108CT was found as a risk to develop obesity 
in children OB (p= 0.04) but observed a protection between 
children OW with the genotype Q192R (p= 0.00) for all geno-
types with dominant and over dominant inheritance studied. 
These results indicate the complex nature of obesity with vari-
ous genetic and environmental factors, possibly influenced by 
the admixture of our population.
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EFFECT OF EXERCISE AND ZINC ON BODY FAT ON MEXICAN ADOLESCENTS WITH 
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Guzmán-Arredondo Oscar D1, Medina-Escobedo Carolina E2 and Rubio-Zapata Héctor A3 
E-mail:namzug871@hotmail.com
1Posgrado Institucional en Ciencias de la Salud, UADY, 2UMAE- Mérida, Instituto Mexicano del Seguro Social, 
3UIICE, Facultad de Medicina, UADY, Mexico
Obesity and metabolic syndrome (MS) have been widely re-
lated. Obesity and MS treatment should include increase 
physical activity and reduce caloric intake. Zinc deficiency is 
common in people with obesity. Zn has physiological implica-
tions for metabolism, so it has been proposed as an adjunct in 
therapeutics of some metabolic diseases. The objective was to 
evaluate the effect of physical exercise and oral zinc intake on 
body fat percentage of adolescents with MS. A randomized 
clinical trial was designed; included 47 adolescents aged 15 
to 18 with MS in accordance with the International diabetes 
federation criteria. The control Group (N = 23) performed 
physical aerobic exercise (60 Minutes/week) and consumed 
a placebo daily; the Study Group (n = 24) in addition to ex-
ercise consumed 50 mg zinc gluconate/day. The intervention 
was 3 months. Fat percentage was determined with a scale 
mark TANITA TBF 300GS, at the beginning and at the end of 
the intervention. The percentage of initial-final fat and varia-
tion percentage (Δ) between men and women of both groups 
were compared with t-Student P < 0.05). Men (28.56 ± 8.64 vs 
27.65 ± 8.29) and women (39.32 ± 8.5 vs 37.56 ± 8.4) treated 
with exercise + placebo reduced body fat at the end of treat-
ment (P=0.02, p<0.001). Men (21.35 ± 7.7 vs 19.05 ± 6.39) 
and women (44.9 ± 6.41 vs 42.65 ± 6.33) treated with exer-
cise + Zinc reduced body fat at the end of treatment (P=0.007, 
p<0.001). Men treated with exercise + Zinc (Δ-10.95 ± 9.11) 
reduced more fat compared to exercise group + placebo (Δ-
2.79 ± 4.15) p=0.039. No differences between women (Δ-5.68 
± 2.81 vs Δ-4.16 ± 3.36, p = 0.211). In conclusion, exercise re-
duces the percentage of body fat in adolescents with SM, how-
ever, in men group zinc consumption increased fat reduction.
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DIMINUTION OF THE METABOLIC RISK IN MAYA CHILDREN AFTER AN 
INTERVENTION WITH A NUTRITIONAL SUPPLEMENT
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The Mexican child population is facing a double burden of 
malnutrition, characterized by the coexistence of chronic 
undernutrition and besides micronutrient deficiencies, and 
also overweight/obesity. Malnutrition is due to the transgen-
erational food poverty and the indigenous areas are the most 
affected. Malnutrition in children leads to insulin resistance 
(IR) and metabolic syndrome (MetS), increasing the suscepti-
bility to develop diabetes and cardiovascular diseases in adult-
hood. The aim was assess the effect of an intervention with a 
nutritional supplement in Maya children with malnutrition. 
The intervention was carried out in 29 Maya children of 9 
years. Previous studies of our group in Maya’s child popula-
tion revealed a frequency of 50%MetS, 34.9%IR, in addition 
to deficiencies of essential micronutrient. The intervention 
was performed during a month with a nutritional supplement 
(code FV-UNAM), which contains vitamins, minerals, anti-
oxidants and omega-3 fatty acids. The protocol has approval 
of the Human Research Ethics Committee of HJM (Hospital 
Juárez de México), both the parents and children signed an in-
formed consent. Biochemical, blood biometrics, anthropom-
etry parameters were measure before and after intervention; 
the nutritional data were collected only during pre-interven-
tion. Statistical analyses were performed using SPSS v21 (P < 
0.05 significant). Data before-intervention showed that 71% 
of children had linear growth problems, 25% were stunted 
and 28% overweight/obesity. 82% had inadequate quality diet, 
with imbalance of macronutrients and more than 70% pre-
sented intake below the IDR of iron, calcium, vitamin A and 
E. 39% had metabolic risk factors, 36% excess distribution of 
peripheral adiposity and 17.9% had MetS. After-intervention, 
the children showed significant decrease in several parameters: 
body fat mass (4%), high blood pressure (30%), hyperglyce-
mia (7%), hypertriglyceridemia (13%), hypercholesterolemia 
(7%) and hypoalphalipoproteinemia (3%). The present study 
demonstrated the beneficial effects in short term of nutritional 
intervention in Maya children. It support by DGAPA202217 
Fellow CONACYT (630518).
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EFFECT OF CITRUS FLAVONOIDS CONSUMPTION ON ATHEROGENIC INDEX OF 
RATS WITH INSULIN RESISTANCE
Barrera Canto Verenice Isabel1, Rubio Zapata Héctor Armando2, Ortiz Andrade Rolffy Rubén3, 
Sánchez Recillas Amanda3
1Facultad de Medicina, UADY, Posgrado Institucional en Ciencias de la Salud; 2Facultad de medicina, UADY, 
Unidad de Investigación Clínica y Epidemiológica; 3Facultad de Química, UADY, Laboratorio de Farmacología 
experimental, Mexico
Insulin resistance (IR) is a mechanism involved in the devel-
opment of chronic metabolic diseases such as diabetes mel-
litus, hypertension, cardiovascular disease and others that 
increase the risk of morbidity and mortality associated with 
atherosclerosis.
Antioxidants have proven to be a therapeutic tool to reduce 
atherogenic risk. Citrus flavonoids are antioxidants derived 
from citrus, whose consumption has been evaluated as an ad-
junct in the treatment of chronic diseases.
The objective was to evaluate the atherogenic index (AI), 
lipid profile and reactivity of the aorta in rats with IR treated 
with citrus flavonoids.
Methodology. IR model was development by consumption 
of 30% sucrose oral, in male Wistar rats. Animals were divid-
ed into 3 groups: control (healthy), with IR + placebo and IR 
treated with 150mg/kg/day of citrus flavonoids (Hesperidin + 
naringenin) for one month. At the end of the treatment, ani-
mals were sacrificed, intracardiac blood was taken and thorac-
ic aorta was dissected out. Serum lipid profile was determined 
by automatic methods. AI=total cholesterol/HDLc. Reactivity 
of the ex vivo aorta through concentration- response curves 
to norepinephrine (NE) and carbachol (Cch) [3.60 x 10-11 to 
1.00 x 10-05 μM].
Results. In control rats AI was 1.11 ± 0.03, IR + placebo rats 
was 1.58 ± 0.09, and IR treated with citrus flavonoids was 1.23 
± 0.05 (ANOVA, p < 0.001, post hoc Tukey). Citrus flavonoids 
reduce AI in animals with IR and have no differences with 
healthy animals. Citrus flavonoids reduced LDLc and total 
cholesterol levels. Reactivity of the Aortas exposed to NE and 
Cch was reduced in animals with IR treated with citrus flavo-
noids compared to animals with IR without treatment.
Conclusion: Citrus flavonoids reduce endothelial dysfunc-
tion and atherogenic risk associated with insulin resistance.
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ASSOCIATION OF SNP RS17817449 AT FTO GENE AND ITS HAPLOTYPE 
(RS17817449/RS9939609) WITH OBESITY IN SCHOOL-AGED CHILDREN  
FROM YUCATÁN, MÉXICO
Magaña Zapata Gisseth Amelia1,2, González Herrera Lizbeth Josefina1, and  
Pérez Mendoza Gerardo José1
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Yucatan, México is the first place of obesity (22.7%) at the 
national level. Single-nucleotide polymorphisms (SNPs) 
rs17817449 (T>G) and rs9939609 (T>A) of the FTO (Fat mass 
and obesity associated gene) gene have been associated with 
obesity in children and adults. Genotypic and allelic frequen-
cies from SNP rs17817449-FTO, as well as the haplotype with 
rs9939609-FTO, were determined to evaluate its association 
with obesity in school-aged children. Anthropometric meas-
ures were obtained: Body Mass Index percentile for age and 
sex (BMIpc), Waist Circumference (WC) and Waist-Height 
index (WHI) in 303 school-aged children, 151 with obesity 
(BMIpc>95) and 152 with adequate weight (IMCpc>15<85). 
Buccal swab samples were obtained for genotyping the SNPs 
rs17817449 and rs9939609 by PCR-RFLPs. The genetic as-
sociation analysis was executed with the statistical softwares 
SNPstats and STATA v.14.0. The three expected genotypes 
were found for the SNP rs17817449 (TT, GT, GG) in the stud-
ied population. The genotypic distribution was adjusted to the 
Hardy Weinberg expectations for school-aged children with 
normal weight (p=0.16), whereas school-aged children with 
obesity was not (p=0.0056). The heterozygous GT genotype 
distribution among school-aged children with and without 
obesity showed significant difference (p=0.0022), suggesting 
association with lower genetic risk for obesity (OR=0.458, 
CI=0.281-0.747). Adjusting for gender, the SNP rs17817449 
showed association with lower risk for obesity only for girls 
(p=0.0048, OR=0.352, CI= 0.171-0.725). The allelic distribu-
tion and the GG risk homozygous genotype did not show 
significant differences (p>0.05). Girls with the heterozygous 
GT genotype showed significantly lower mean measures of 
BMIpc (p=0.0195) and ICE (p=0.0194). Haplotype frequency 
distribution (rs17817449/rs9939609) showed that the most 
and the least frequent combinations were T/T (60.01%) and 
G/A (1%) respectively. In both groups, with obesity as well as 
with normal weight, the most frequent combination was T/T 
(61.55% and 58.31%, respectively), in the studied population 
from Yucatán, México
Palabras clave: FTO, rs17817449, rs9939609, haplotype, 
obesity in school-aged children, Yucatan.
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Mexico is the second country in the world in overweight and 
obesity with prevalence in adults of 39% and obesity 26%; it is 
also the fifth with more people with type 2 diabetes mellitus 
(T2DM). Obesity affects the function of the foot, structurally 
tend to be flatter and present greater plantar soft tissue thick-
ness. Adults with obesity have higher levels of plantar pres-
sure, which leads to changes in the footprint, affects postural 
stability and changes in gait. People with T2DM have limited 
mobility and a decrease in strength that are factors that in-
crease the risk of falls. This study determines the association 
of obesity and alterations in the footprint with the risk of falls 
in people with T2DM. This cross-sectional study included 37 
adults (≥40 years and ≥5 years with a diagnosis of T2DM), the 
BMI was calculated also ranges of movement, muscle strength 
(Daniels test), footprint (Hernández-Corvo protocol) and risk 
of falls (Tinetti). 65% presented obesity of which 68% had a 
high risk of falls and presented planus foot, 24% overweight 
with 44% high risk of falls, normal and cavus foot, and 11% 
normal weight with 75% high risk of falls and normal and ca-
vus foot. There was not a significant difference between the 
risk of falls and the groups (p> 0.05).
Despite not finding a difference in the risk of falls between 
the groups, planus feet were only present in patients with obe-
sity. A physiotherapeutic evaluation is required to identify 
the factors that contribute to the increase of gait alterations 





GSTT1 AND EXPRESSION OF MIR-222 AS A RISK FACTOR TO DEVELOP OBESITY  
IN YUCATECAN SCHOOLCHILDREN
González Arce Larissa Michelle1, González Herrera Lizbeth2, May Hau Abraham3,  
Pérez Mendoza Gerardo2, and Lara Riegos Julio4
1Postgraduate student, 2Laboratory of Genetics, 3Bachelor student, 4Laboratory of Molecular Biology and 
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Childhood obesity is a chronic disease that reduces the life 
expectancy and quality of life. In Yucatan, the prevalence of 
excess weight reaches 50%, exceeding the national average of 
34%. The etiology is multifactorial, explained by external and 
internal factors. MicroRNAs explain the regulation of gene 
expression, where miR-222 modulates genes associated with 
inflammation and insulin resistance. The deletion of the gene 
glutathione-S-transferase (GSTT1) means an absence of en-
zymatic antioxidant activity to reactive oxygen species which 
increases the susceptibility to chronic inflammatory condi-
tions. This study associates the genetic variant by deletion of 
the GSTT1 gene and the levels of expression of miR-222 with 
characteristics of obesity in schoolchildren in Mérida, Yu-
catán. A case-control study was conducted; anthropometric 
data and peripheral blood sample were obtained for measure-
ment of biochemical parameters, genetic analysis, genotyp-
ing GSTT1 and expression of miR-222 by polymerase chain 
reaction. For the statistical analysis, Pearson’s r correlation, 
Chi-square and linear regression were performed. Data of 60 
schoolchildren were analyzed (30 normal weight, 30 with obe-
sity). The association of GSTT1 with the nutritional diagnosis 
resulted in no significant difference (p = 0.583). The expres-
sion of miR-222 showed a significant positive correlation with 
creatinine levels (p = 0.047) and metabolic index (p = 0.033). 
The correlation of the GSTT1 genotypes and the expression 
of miR-222 with other anthropometric and biochemical vari-
ables was not significant. The association by linear regression 
of miR-222 and Body Mass Index resulted in R2 = 0.013, p = 
0.388. No significant association was found between the geno-
types of the GSTT1 gene and the expression levels of miR-222 
with obesity, with limitations in the sample size. However, the 
expression of miR-222 correlates significantly with creatinine 
levels and metabolic index.
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The association between altered sleep and body mass index 
(BMI) is important due to the global obesity epidemic. 72.5% 
of Mexican adults present either overweight or obesity and 
59% of them sleep less than 7 hours per night. The purpose 
of this study is to compare sleep quality and the BMI between 
bed or hammock sleepers. 69 college students [53% female; 21 
± 1.6 years old (mean ± SD)] participated. Participants were 
randomized into two conditions: if they sleep in a bed (n= 
33) or in a hammock (n= 36). The objective sleep was meas-
ured through an actigraphy device, during seven days a week, 
BMI was obtained with a weighing machine and altimeter 
and it was applied the Epworth Scale to identify sleep habits 
and sleepiness (subjective sleep). Two parameters of actigra-
phy were significant: Activity index (ACTX) and Mean sleep 
episodes (MSEP). No significant differences between groups 
were found in subjective sleep parameters. In relation with 
BMI, hammock-users obtained 2.82 points above bed users 
(p = 0.010). Correlation between ACTX with BMI was sig-
nificant in males that sleep in hammock (r = 0.60, p < 0.01). 
In conclusion, the study shows that hammock users have less 




POLYMORPHISM OF THE GENE GLUTATHIONE TRANSFERASE THE TA 1 IN 
SCHOOLCHILDREN WITH OBESITY AND NORMAL WEIGHT IN MÉRIDA, YUCATÁN
May Hau Marcos Abraham, Pérez Mendoza Gerardo, Gonzalez Arce Larissa, and  
Gonzalez Herrera Lizbeth
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, UADY, Mexico
The present study was carried out with the purpose of deter-
mining the frequency of the GSTT1 genotypes in 79 school 
children in the city of Mérida, Yucatán, associating it with ex-
cess weight in public schools, taking into account the nutrition-
al value of each participant. The requirements to be included 
in the study were that schoolchildren aged 6 to 12 years, were 
in a range of normal weight or obesity with the WHO BMI 
ranges (taking into account anthropometric measurements 
and deletions of the gene as the study variables). Parents were 
previously given letters of consent to agree or refuse to be part 
of the investigation. Each of the students evaluated was given 
a small nutrition consultation after evaluating their nutri-
tional status through anthropometric measurements, dietary 
evaluation and biochemistry. Once the blood was obtained, 
DNA extraction was performed in the genetic laboratory of 
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, 
using the Bourne method with a change in a step instead of 
using sodium chloride, sodium perchlorate was used to ob-
tain a larger condensed sample. Once the DNA samples were 
obtained, end- point PCR samples were made to perform elec-
trophoresis in 1% agarose gel. The results of the research in 
schoolchildren were that the genotyping of the deletion of the 
genes of the schoolchildren did not show an association with 
excess weight, however there was a significant difference in 
the measurement of the WAIST-HIP INDEX and the WAIST- 
STATURE INDEX in the minors who had the gene deletion.
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THE ROLE OF PLATELETS IN TYPE 2 DIABETES PATHOGENESIS
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Type 2 diabetes is a chronic multifactorial disease involving 
several macro and microvascular disfunctions, as a conse-
quence of chronic hyperglycemia. These complications could 
be favored by platelet count alterations, as well as functional 
and morphological anomalies, leading to thrombotic and car-
diovascular diseases. Hyperactivation of platelets in type 2 di-
abetes patients increase the risk to develop cardiovascular and 
thrombotic events. This platelet hyperactivity could be due to 
an increase in sensitivity to epinephrine, ADP and trombine, 
as well as the presence of high levels of thromboxane and dis-
equilibrium of magnesium and calcium ions inside the cell. 
Additionally, higher expression of surface adhesion molecules 
as CD63, p-selectin, CD49b, CD36 and CD31 in platelet 
membrane and the increase in AMPc and insulin sensitivity, 
are the main factors contributing to increase in adhesion and 
platelet aggregation. Platelets have been recently considered as 
inflammatory immunomodulators, making them important 
players in chronic inflammation in type 2 diabetes pathogen-
esis. On the other hand, adipose tissue has been implicated 
in thrombus formation, so our goal was to present a model 
about possible alterations of platelet function involved in type 
2 diabetes and its correlation with adipose tissue increase, in 





USEFULNESS OF THE TRIGLYCERIDES/HDL-C INDEX TO IDENTIFY THE FATTY 
LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME
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Fatty liver disease is a frequent complication of the metabolic 
syndrome and its main histopathological characteristic is the 
marked steatosis by triglyceride (TG) microvesicles accumu-
lation in the hepatic parenchyma. Insulin resistance (IR) is a 
mainstay factor in hepatic steatosis development. Previously, 
the TG / HDL-C index has been used as a metabolic marker 
related to IR and cardiovascular risk. To evaluate the ability 
of the TG/HDL-C index as a metabolic marker to identify the 
risk of fatty liver disease in patients with metabolic syndrome. 
Transversal study. Patients with metabolic syndrome were 
included, who underwent lipids and serum lipoproteins de-
termination. The fatty liver disease diagnosis was performed 
using the controlled attenuation parameter (CAP) of transient 
elastography (Fibroscan®), method validated, sensitive and 
specific for liver steatosis detection. Analysis of the receiver 
operative characteristic (ROC curve) was used. It was deter-
mined the sensitivity, specificity, and area under the curve 
(AUROC) of the TG/HDL- C index. Optimal cut-points were 
identified and analyzed for predictive power. Pearson correla-
tion between the index and the value of the CAP was obtained. 
It was considered p≤0.05 as significant. The analysis was car-
ried out in the statistical software SPSS® v.22. We Included 
68 patients, 60.3% were men. The age average was 50.9±12.1 
year. The TG/HDL-C index had AUROC value of 0.78 (95% 
CI: 0.66-0.90, p<0.01). The best index cut-off point was ≥3. 49 
with sensitivity of 70% and specificity of 94%, positive predic-
tive value 97% and a negative predictive value of 50% for the 
presence of fatty liver disease. A positive correlation between 
the index and CAP value was found (r=0.437, p<0.01). The 
TG/HDL-C index is a simple and useful metabolic marker 
associated with the presence of fatty liver disease in patients 
with metabolic syndrome.
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BARIATRIC SURGERY-ASSOCIATED DNA METHYLATION REMODELING  
IN ADIPOSE TISSUE FROM OBESE PATIENTS
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Obesity and its comorbidities are complex diseases where 
the interaction of environmental and genetic factors for their 
origin is required. The genetic factors identified to date only 
explain a small part of the variation of the body mass index 
(BMI). Recently it has been reported that epigenetic altera-
tions, especially DNA methylation, may have an important 
role in the pathogenesis of metabolic diseases. Bariatric sur-
gery is a radical intervention in the treatment of obesity and 
co-morbidities and there is still little information about epige-
netic remodeling and its relation to the improved metabolic 
health that is associated with weight reduction after surgery. 
Forty one patients with obesity submitted to bariatric surgery 
were included. All patients were Mexicans, with similar base-
line characteristics between groups, 21 with diabetes (OD) 
and 20 without (OB). A subcutaneous adipose tissue (SAT) 
biopsy was collected at the surgery time. Global DNA meth-
ylation profiles were analyzed using Illumina HumanMeth-
ylation450K Bead Chip. Methylation profiles were contrasted 
between groups the day of intervention and six months after. 
DAVID was used to enrichment analysis. We searched for dif-
ferentially methylated CpG sites (DMCs) in OD, comparing 
with OB patients in the day of surgery. A CpG site was defined 
as DMC when a p value<0.05 and at least 0.05 absolute mean 
methylation difference. Six months after the surgery, a SAT 
biopsy was collected for all patients. DNA methylation pro-
files were evaluated and compared with those at the moment 
of surgery. We found diverse DMCs in OD compared with 
OB patients at the time of surgery. Analysis of DNA meth-
ylation after 6 months of surgery, showed changes in profiles 
in both OD and OB patients. Many of DMCs reversed their 
differences between both groups. We also found sites with a 
high correlation between DNA methylation level and clinical 
parameters.
